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Abstract 
Transcription factors (TFs) occupy chromatin to coordinate widespread regulation of gene expression 
programs that define cellular identity. These proteins bind diverse DNA sequences genome-wide and in a 
non-uniform manner across the cell cycle, yet the spatial and temporal determinants of TF chromatin 
occupancy are largely unknown. First, to define DNA sequence determinants of in vivo TF binding, we 
developed an approach that exploits natural genetic variation between highly similar erythroid cell lines. 
From ChIP-seq data we were able to directly identify extensive single nucleotide variants that discriminate 
these cell lines from each other. By measuring the impact of these variants on TF ChIP-seq binding 
intensities, we defined at single nucleotide resolution the binding determinants of the GATA1, TAL1, and 
CTCF factors. We also identified contextual sequences that, in addition to a TF’s core DNA motif, dictate 
TF specificity and modulate TF binding when mutated. Together, these studies present new approaches 
and biological insights regarding the DNA sequence requirements for TF binding to chromatin. Next, we 
tested whether TF chromatin occupancy is dynamic across the cell cycle. In particular, we asked whether 
the BRD4 TF binds chromatin in erythroid cells during mitosis, and whether it might function as a 
bookmark of transcriptional programs across mitosis. While we find that BRD4 is preferentially enriched 
during mitosis at erythroid-specific genes in the G1E-ER4 erythroid cell line, transient removal of BRD4 
from chromatin during mitosis does not impair the reactivation of erythroid-specific programs following 
mitosis. Thus, BRD4 does not function as a bookmark of transcription, and instead we considered that it 
might passively bind to acetylated histones during mitosis. Given that the histone PTM landscape during 
mitosis has not been previously characterized, we used histone mass spectrometry and genome-wide 
location analysis to find extensive preservation of H3K14ac, H3K122ac, and H4K16ac on mitotic 
chromatin. Furthermore, these marks are predictive of BRD4 and Pol II binding to mitotic chromatin and 
are preferentially enriched at erythroid-specific genes during mitosis, suggestive of a role in mitotic 
bookmarking. Together, these studies reveal new insights about the mechanisms by which transcription 
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MINING THE SPATIAL AND TEMPORAL CONTEXT BY WHICH 
TRANSCRIPTION FACTORS OCCUPY CHROMATIN 
Vivek Behera 
Dr. Gerd A. Blobel 
Transcription factors (TFs) occupy chromatin to coordinate widespread regulation 
of gene expression programs that define cellular identity.  These proteins bind diverse 
DNA sequences genome-wide and in a non-uniform manner across the cell cycle, yet the 
spatial and temporal determinants of TF chromatin occupancy are largely unknown. First, 
to define DNA sequence determinants of in vivo TF binding, we developed an approach 
that exploits natural genetic variation between highly similar erythroid cell lines. From 
ChIP-seq data we were able to directly identify extensive single nucleotide variants that 
discriminate these cell lines from each other. By measuring the impact of these variants 
on TF ChIP-seq binding intensities, we defined at single nucleotide resolution the binding 
determinants of the GATA1, TAL1, and CTCF factors. We also identified contextual 
sequences that, in addition to a TF’s core DNA motif, dictate TF specificity and modulate 
TF binding when mutated. Together, these studies present new approaches and biological 
insights regarding the DNA sequence requirements for TF binding to chromatin. Next, we 
 vii 
tested whether TF chromatin occupancy is dynamic across the cell cycle. In particular, we 
asked whether the BRD4 TF binds chromatin in erythroid cells during mitosis, and 
whether it might function as a bookmark of transcriptional programs across mitosis. While 
we find that BRD4 is preferentially enriched during mitosis at erythroid-specific genes in 
the G1E-ER4 erythroid cell line, transient removal of BRD4 from chromatin during 
mitosis does not impair the reactivation of erythroid-specific programs following mitosis. 
Thus, BRD4 does not function as a bookmark of transcription, and instead we considered 
that it might passively bind to acetylated histones during mitosis. Given that the histone 
PTM landscape during mitosis has not been previously characterized, we used histone 
mass spectrometry and genome-wide location analysis to find extensive preservation of 
H3K14ac, H3K122ac, and H4K16ac on mitotic chromatin. Furthermore, these marks are 
predictive of BRD4 and Pol II binding to mitotic chromatin and are preferentially enriched 
at erythroid-specific genes during mitosis, suggestive of a role in mitotic bookmarking. 
Together, these studies reveal new insights about the mechanisms by which transcription 
factors occupy chromatin.  
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CHAPTER 1: Introduction 
 
Transcription factors (TFs) 
Lineage-specific transcriptional regulation  
Multicellular organisms contain diverse types of cells that carry out distinct 
functions based on factors such as cell identity and location within an organ or within the 
organism as a whole. The basis for cellular diversity despite an identical genetic sequence 
in every cell is transcriptional diversity, by which cells can produce distinct RNAs from the 
same DNA content. Recent sequencing technologies are making it possible to access a 
wealth of information describing transcriptional diversity between distinct cell types. 
These studies have validated the finding from classic genetic studies that cell type choices 
are highly regulated and coordinated processes (Davidson, 2010). A central component of 
these regulatory networks is the group of proteins known as transcription factors. 
Transcription factors (TFs) are proteins that physically bind to chromatin and 
regulate transcription via either activation or repression. TFs typically bind short 6-12 bp 
DNA recognition motifs, although some factors, for example BRD4, bind chromatin 
without such a recognition sequence by instead associating with other TF proteins or with 
 2 
histones (Shi and Vakoc, 2014). Once associated with chromatin, TFs can regulate 
transcription in a number of ways. TFs might regulate the initiation of transcription at a 
given gene by physically interacting with transcriptional coactivating proteins, such as the 
Mediator complex, general transcription factors, and RNA Polymerase II (Tamar and 
Kadonaga, 2010). Alternatively, they might alter the local chromatin landscape in an 
activating or repressive manner by recruiting histone modifying enzymes, chromatin 
remodeling proteins, or even other TFs. TFs can also participate in the formation of long-
range chromatin loops that bridge enhancer-promoter regions to activate transcription 
(Kadauke and Blobel, 2009). Finally, TFs can regulate the elongation of transcription by 
regulating RNA Pol II pause-release (Rahl et al., 2009). 
While a given TF can profoundly affect gene expression by regulating thousands of 
genes at once, there are far fewer TFs that exist than the number of cell types present in a 
metazoan organism. It is therefore generally assumed that cell identity is specified by 
multiple transcription factors working in combination (Bottardi et al., 2007). In fact, TF 
binding tends to occur in dense clusters in both Drosophila (Moorman et al., 2006) and 
humans (Yan et al., 2013). TFs have been found to collaborate in a number of ways. Some 
TFs have been found to cooperatively bind chromatin in a complex where TFs bind to each 
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other and directly to DNA, thus stabilizing each other’s binding (Kerppola and Curran, 
1991; Panne, 2008). TFs can also stabilize each other’s binding by each interacting with a 
common coactivator protein on chromatin (Merika et al., 1998). Finally, TFs can impact 
the binding of other TFs by impacting local DNA accessibility. This might be done by 
activating chromatin remodeling (Biddie et al., 2011), by actively blocking nucleosome 
positioning (Voss et al., 2011), or by inducing architectural changes such as DNA bending 
(Falvo et al., 1995). Combinatorial TF binding creates a diverse mode of transcriptional 
regulation that allows for hundreds or thousands of distinct cell lineage fate choices to be 
established and maintained within multicellular organisms.  
Dysregulation in disease 
The widespread regulatory functions of transcription factors make these proteins 
an important target in disease. Disruption of transcription factor functions can occur 
either by mutation or altered expression of the TF itself, or by mutation of the DNA binding 
substrate for TF binding. Human TF coding mutations are more likely than other coding 
gene mutations to result in a detectable phenotype, and genome-wide association study 
(GWAS) signals for multiple diseases are enriched in TF genes (Lambert et al., 2018). TF 
mutations within a DNA binding domain (DBD) often alter the set of genomic locations 
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that a TF will bind (Barrera et al., 2016), which can have widespread effects on gene 
expression and cellular identity. TF mutations outside of DBDs can alter function by 
instead modifying interactions with activating or repressive cofactors of transcription 
(Muller and Vousden, 2014). Finally, mutations can fall within DNA sequences that 
regulate TF expression, thus altering global TF protein levels and impacting disease 
outcomes (Sur and Taipale, 2016). 
Disruptions to the other side of the TF-DNA interaction, TF-bound DNA 
sequences, can have similarly important roles in disease and common phenotypic 
variation. For example, a single intronic polymorphism in the FTO locus alters enhancer 
function by disrupting binding of the ARID5B TF, which ultimately alters adipose cell fate 
and contributes to a metabolic/obesity disease phenotype (Claussnitzer et al., 2015). 
Together, it has been estimated that 85-95% of GWAS signals occur in likely regulatory 
regions (Maurano et al., 2012) that are enriched for high chromatin accessibility and TF 
occupancy (Epstein, 2009; Ernst et al., 2011). However, current efforts to assess the 
phenotypic impact of a regulatory mutation are limited by our incomplete understanding 
of the determinants of TF binding. Moreover, the complexity of combinatorial TF 
regulation means that mutations might impact TF binding and transcriptional regulation 
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in independent ways. A better understanding of how TFs occupy chromatin and exert 
regulatory function is critical to understanding the full extent of their role in disease and 
common genetic variation. 
 
Spatial regulation of TF binding  
Transcription factor motifs 
In vitro binding assays and structural studies have been instrumental in identifying 
the DNA sequences that a transcription factor can bind. The development of a technology 
such as SELEX (systematic evolution of ligands by exponential enrichment) (Kinzler and 
Vogelstein, 1990; Tuerk and Gold, 1990) allowed for the identification for a large number 
of DNA-binding proteins of possible DNA sequences with which these proteins interact in 
vitro. Advances in sequencing as well as the development of complementary methods, 
such as electrophoretic mobility shift assays (EMSA), nuclease footprinting (Lane et al., 
1992), protein binding microarrays (PBM) (Bulyk et al., 2001), and high-throughput 
SELEX (Jolma et al., 2010), have made it possible to refine the specificity and accuracy of 
these in vitro readouts and to test longer DNA oligomers for TF binding. While these 
methods can assay the relative affinity of a TF to a wide range of DNA sequences, they 
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typically lack in vivo regulatory components of TF binding, such as DNA shape, chromatin 
accessibility, and the particular cofactor environment in a given cell type. 
The development of chromatin immunoprecipitation with a deep sequencing read-
out (ChIP-seq) (Johnson et al., 2007) made it possible to identify TF sequence binding 
preferences in vivo. A typical ChIP-seq experiment will identify as many as thousands to 
tens of thousands of binding sites for a TF in a particular cell type. The DNA sequences 
found at these binding peaks can then be tested, using tools such as MEME (Bailey and 
Elkan, 1995), for the presence of enriched TF binding motifs. Enriched motifs are 
commonly represented as position-weight matrices (PWMs) (Stormo and Zhao, 2010) 
that describe the contribution of different possible nucleotides in a TF motif to overall 
binding affinity. TF motifs, however, are typically 6-12 bp long and are thus predicted to 
occur genome-wide at many more locations than a TF will actually bind. In fact, the 
presence of a TF motif has limited value in predicting actual TF occupancy (Fujiwara et 
al., 2009; Zhang et al., 2009). TF motifs, even when consistent between in vitro and in 
vivo studies, offer an incomplete picture of the sequence requirements that define 
transcription factor chromatin occupancy. 
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GATA1 
GATA1 is a transcription factor that is required for the maturation of red blood 
cells (Pevny et al., 1991). It was first identified as a protein that binds an enhancer region 
(Wall and Grosveld, 1988) and activates transcription of the beta-globin gene (Evans et 
al., 1988). GATA1-deficient mice are incapable of both primitive and definite 
erythropoiesis and arrest at the proerythroblast stage (Weiss et al., 1994), resulting in 
death from severe anemia in early embryogenesis (E10.5) (Fujiwara et al., 1996). Several 
types of human congenital anemias have been associated with GATA1 mutations 
(Campbell et al., 2013; Fujiwara et al., 1996), and GATA1 has been shown to be 
additionally required for proper differentiation of megakaryocytes, eosinophils, and mast 
cells (Crispino, 2005). 
The study of GATA1 in transcriptional regulation has been greatly facilitated by the 
development of an immortalized GATA1-deficient proerythroblast cell line, named G1E 
cells (Weiss et al., 1997), and a sub-clone of these cells that contain an estrogen inducible 
form of GATA1, termed G1E-ER4 cells (Gregory et al., 1999). Studies using these cells 
suggest that GATA1 promotes both widespread gene activation and repression (Welch et 
al., 2004; Yu et al., 2009). While the mechanisms by which GATA1 can both activate and 
repress transcription are multifactorial, it has been shown that GATA1 recruits activating 
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and repressive cofactors to chromatin in distinct complexes. For example, GATA1 forms a 
transcriptional transactivating complex with the proteins LMO2, LDB1, TAL1, and E2A 
(Wadman et al., 1997). Alternatively, GATA1 can form both activating and repressive 
complexes via interactions with FOG1 and the NuRD complex (Letting et al., 2004; Miccio 
et al., 2010). In total, GATA1 has been shown to physically interact or to colocalize on 
chromatin with a number of TFs (Ferreira et al., 2005), yet likely binds chromatin in a 
wider array of complexes and cofactor configurations than can be currently identified.  
GATA1 contains two zinc finger domains capable of directly binding DNA. The C-
terminal zinc finger is responsible for binding to the consensus GATA1 motif, which both 
in vitro and later ChIP-seq studies have defined as the WGATAR DNA sequence (Evans et 
al., 1988; Wall and Grosveld, 1988). The N-terminal zinc finger contributes to a stable 
(Martin et al., 1990) and specific (Trainor et al., 1996) interaction with DNA and mediates 
cofactor interactions, especially with FOG1 (Tsang et al., 1997). Together, these zinc finger 
domains, along with GATA1’s N-terminal transactivation domain, mediate the interaction 
of GATA1 with DNA and with other cofactor proteins. However, it remains generally 
unclear how GATA1-binding cofactors, several of which directly bind DNA, might 
influence the chromatin occupancy of GATA1. GATA1 chromatin occupancy can be 
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collaboratively regulated by both DNA binding proteins such as KLF1 (Kang et al., 2015) 
and by non-DNA binding proteins such as FOG1 (Chlon et al., 2012; Letting et al., 2004; 
Pal et al., 2004) and LDB1 (Li et al., 2013), although only FOG1 has been described to 
impact GATA1 binding on a genome-wide scale. Identifying the genetic determinants of 
GATA1 binding beyond the consensus WGATAR motif might provide insight into the 
specificity of GATA1 binding and into the genomic localization of different types of GATA1-
containing complexes. 
CTCF 
CCCTC-binding factor (CTCF) is a ubiquitously expressed TF that is required for 
viability and differentiation in multiple cell types, including erythroid cells (Torrano et al., 
2005). CTCF participates in multiple aspects of transcriptional regulation, including 
mediating enhancer-promoter loops, long-range chromatin architecture such as TADs, 
and regulating transcriptional pausing (Ong and Corces, 2014). CTCF binds DNA using a 
highly conserved DNA binding domain that contains 11 zinc fingers (Ohlsson et al., 2001). 
It binds as many as 55,000-65,000 locations in mammalian genomes (Chen et al., 2012), 
of which a large proportion is relatively tissue invariant. However, up to 30-60% of these 
sites have been found to be cell-type specific (Chen et al., 2012; Dubois-Chevalier et al., 
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2014; Plasschaert et al., 2014), suggesting substantial regulation of CTCF binding beyond 
the core CTCF motif. CTCF has recently been shown to interact with the LDB1 complex in 
erythroid cells and facilitate tissue-specific gene activation (Lee et al., 2017), yet it remains 
unclear whether interactions such as these regulate CTCF binding to chromatin in 
differentiated cell types.  
Taking advantage of genetic variation 
Exploiting natural genetic variation in TF ChIP-seq data sets provides a means to 
pinpoint nucleotides critical for direct TF binding as well as to identify contextual 
regulators that function outside of core binding motifs. It allows direct comparisons 
between different alleles or individuals that have similar, if not identical, contextual cis 
attributes and trans-acting environments and yet contain a small number of 
discriminatory genetic polymorphisms. For example, comparative ChIP-seq and DNase-
seq between different strains of mice has identified sequence variants in cofactor motifs 
that affect PU.1 and C/EBPɑ binding (Gosselin et al., 2014; Heinz et al., 2013). Others have 
identified allelic imbalance in TF binding by gathering ChIP-seq or DNase-seq data in 
hybrid mouse strains13 or in human LCLs (Kilpinen et al., 2013; Tehranchi et al., 2016) 
and patient tissues (Maurano et al., 2015) that are replete in sequence variants. 
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A rich source of natural genetic variation can be found among the extensively 
characterized ENCODE cell lines (Dunham et al., 2012). Especially useful are lines from 
distinct genetic backgrounds but representing the same cell types with highly similar 
transcription profiles. For example, the murine G1E-ER4 and MEL erythroid cell lines are 
derived from different genetic backgrounds and are each commonly used for studying 
erythroid differentiation. These cells can be induced to differentiate, upon which broadly 
similar sets of genes are induced or repressed when compared to primary murine 
erythroblasts (Pishesha et al., 2014; Welch et al., 2004).  Moreover, rich genome-wide 
datasets on chromatin features are available for G1E-ER4, MEL and primary erythroblasts 
through ENCODE (Yue et al., 2014). By connecting naturally occurring genetic variation 
to differences in TF binding and chromatin accessibility, we might gain a better 
understanding of the DNA sequence determinants of TF chromatin occupancy. 
Temporal regulation of TF binding  
Mitotic bookmarking: hypothesis and implications 
Transcription factor regulatory networks are not only diverse in the types of 
cofactor complexes that regulate spatial localization of TF binding. TFs have been shown 
to bind and release from chromatin on the order of seconds (Morisaki et al., 2014) , leading 
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to diversity in the subset of TF  binding sites are occupied at any given time. It remains 
largely unclear what factors might regulate the on and off kinetics of a TF-DNA interaction 
(Swift and Coruzzi, 2017). Actively dividing cells additionally undergo temporal dynamics 
on a longer scale as they move through the cell cycle. In particular, for decades it has been 
observed that during mitosis, dividing cells undergo a dramatic condensation of their 
chromosomes that is accompanied by the silencing of transcription and the widespread 
removal of most transcriptional regulatory proteins from chromatin (MA et al., 1995; 
Prescott and Bender, 1962). Additionally, recent work has shown that chromatin 
architecture domains, many of which exist in a tissue-specific manner, are widely lost 
during mitosis (Naumova et al., 2013), raising questions about how a cell might reform 
these domains once mitosis is complete. The task of re-starting entire transcriptional 
networks in early G1 creates the possibility for errors in gene expression (Hsiung et al., 
2016) that might prevent faithful maintenance of cell identity (Halley-Stott et al., 2014). 
Together, these findings suggest that the robust maintenance of cellular identity across 
mitosis might require molecular “bookmarks” of transcription to create a memory of 
which genes should be activated or repressed. 
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Mitotic bookmarks have been postulated to be chromatin-associated factors such 
as transcription factors, chromatin accessibility, and histone modifications. The 
identification of a mitotic bookmark requires two things: 1) the chromatin feature should 
be present on mitotic chromatin, and 2) mitosis-specific removal of the feature from 
chromatin should impact the resumption of transcription following mitosis. While 
immunofluorescence studies offered early insight into proteins that might associate with 
mitotic chromosomes, the development of ChIP-seq and techniques for highly pure 
preparations of mitotic cells (Campbell et al., 2014) have facilitated the rapid identification 
of a number of TFs bound to mitotic chromatin. GATA1 (Kadauke et al., 2012) and FoxA1 
(Caravaca et al., 2013) were among the earliest TFs to be associated with mitotic chromatin 
on a genome-wide scale. More recently, multiple key pluripotency TFs, including Sox2 
(Deluz et al., 2016; Teves et al., 2016), Esrrb (Festuccia et al., 2016), Oct4 (Liu et al., 2017), 
and Klf4 (Liu et al., 2017), have also been identified to bind mitotic chromatin. The finding 
that multiple transcription factors remain widely bound to mitotic chromatin was perhaps 
surprising, given the gross condensation that might impact DNA accessibility for a TF. 
However, studies of chromatin accessibility during mitosis show widespread retention of 
accessibility of TF-bound regions (Hsiung et al., 2015), suggesting that accessibility may 
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function as an independent bookmark of transcription or be a requirement for 
maintenance of a bookmark such as a TF. One of the principal challenges in connecting 
the presence of a chromatin feature during mitosis to a role in bookmarking is the high 
degree of genomic colocalization between TFs, chromatin accessibility, and histone marks. 
While some of these may have functional roles as mitotic bookmarks, others might 
passively remain on mitotic chromatin in the same genomic locations; functional studies 
should aim to distinguish between these possibilities. 
Demonstrating that proteins bound to mitotic chromatin have a functional role in 
impacting transcriptional reactivation has traditionally been a significant challenge. The 
earliest studies on potential mitotic bookmark TFs tested their roles in the resumption of 
transcription by using pan-cell-cycle knock-down or knock-out approaches (Blobel et al., 
2009; Caravaca et al., 2013; Dey et al., 2009; Lodhi et al., 2014; Zhao et al., 2011). In 
perturbing the protein levels of key transcriptional regulatory factors across the entire cell 
cycle, however, these approaches cannot clearly attribute any delays in transcription 
reactivation during G1 specifically to the function of a mitotic bookmark. The development 
of mitosis-specific TF degradation approaches provided a partial solution and similarly 
found transcriptional delays following mitosis in multiple cell types (Festuccia et al., 2016; 
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Kadauke et al., 2012; Liu et al., 2017), as well as defects in pluripotency maintenance 
(Deluz et al., 2016; Liu et al., 2017) and neuroectodermal differentiation (Deluz et al., 
2016) in ES cells. However, these effects could have resulted from persistently reduced TF 
protein levels during early G1. Together, these functional data provide compelling but 
incomplete evidence for the longstanding hypothesis that mitotic chromatin-bound 
proteins might be required for transcriptional reactivation following mitosis. The 
limitations of these approaches underlie the need to develop transient perturbations of 
potential mitotic bookmarks so that the functional impact of mitotic chromatin occupancy 
can be clearly assessed. 
BRD4 
Among the earliest “bookmarking” proteins to be described is BRD4 (also known 
as mitotic chromatin associated protein MCAP) (Dey et al., 2000). BRD4 is a chromatin-
binding protein that has been recently implicated as therapeutic target in cancer (Dawson 
et al., 2012; Shi and Vakoc, 2014) and autoimmune disease (Belkina and Denis, 2012). 
BRD4 deletion causes early embryonic lethality in mice (Houzelstein et al., 2002), and 
knockout of BRD4 results in a severe growth defect in the G1E-ER4 erythroid cell line 
(Stonestrom et al., 2015). These critical functions are connected to multiple roles in 
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regulating transcription (Devaiah et al., 2016b), such as transcriptional initiation 
(Rahman et al., 2011), transcriptional elongation (Moon et al., 2005), Pol II 
phosphorylation (Devaiah et al., 2012), and histone acetylation (Devaiah et al., 2016a). 
BRD4 has been identified as a transcriptional activator of oncogenic driver proteins in 
multiple cancers, and its depletion has been noted to slow tumor cell growth and promote 
widespread transcriptional changes that lead to differentiation away from a malignant 
phenotype (Ott et al., 2012; Zuber et al., 2011). These findings have driven the 
development of small molecular competitive inhibitors of BRD4 binding that are currently 
being tested for efficacy in multiple cancers (Filippakopoulos and Knapp, 2014; 
Filippakopoulos et al., 2010).  
BRD4 contains two acetylation-binding bromodomains with which it binds to both 
histone acetylation and acetylated transcription factors (Shi and Vakoc, 2014). Early 
experiments used immunofluorescence, ChIP-qPCR, and photobleaching experiments to 
show that BRD4 can bind mitotic chromatin in multiple cell types (Dey et al., 2000, 2003, 
2009; Nishiyama et al., 2006; Yang et al., 2008; Zhao et al., 2011) in a manner dependent 
on its acetylation-binding bromodomains (Dey et al., 2003). The presence of BRD4 on 
mitotic chromatin, as well as its widespread role in transcriptional regulation and its 
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efficacy as a therapeutic target in multiple cancers, has created widespread acceptance of 
BRD4 as a mitotic bookmark (Bradner, 2011). This conclusion has been supported by 
whole-cell-cycle knockdown (Dey et al., 2009; Zhao et al., 2011) and competitive inhibition 
(Zhao et al., 2011) of BRD4, which leads to diminished Pol II recruitment and 
transcriptional activity following mitosis. However, challenges in interpretation of whole-
cell-cycle perturbation experiments leave the functional role of mitotic chromatin-bound 
BRD4 an open question. It also remains unclear whether BRD4 binding during mitosis 
occurs genome-wide, and what factors might regulate its genome-wide binding landscape 
during mitosis.  
Histone PTMs in mitosis 
Histone PTMs represent one of the more likely mechanisms by which mitotic 
bookmarking might take place. Histone methylation and acetylation PTMs have been 
shown to turnover on much slower time-scales than TF binding (Zee et al., 2010), 
suggesting that histone PTMs might be maintained on mitotic chromatin either passively 
or actively. Furthermore, histone PTMs are bound by a number of transcriptional 
regulatory proteins (Yun et al., 2011), including BRD4, suggesting that recruitment of 
these proteins to histone PTMs during early G1 might provide for faithful reactivation of 
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transcription. At select locations, various histone PTMs, including H3K4me2/3 (Blobel et 
al., 2009), H3K9me3 (Hathaway et al., 2012), H4K5ac (Zhao et al., 2011), and H3K27ac 
(Hsiung et al., 2016; Liu et al., 2017), can be found on mitotic chromatin. Notably, 
H3K9me3 has been shown to be stable across many rounds of cell division in the absence 
of the HP1⍺ stimulation for H3K9me3 formation (Hathaway et al., 2012). However, even 
for histone PTMs that might be retained on mitotic chromatin, it cannot be assumed that 
they occupy the same locations during interphase and mitosis. For example, TSS-proximal 
nucleosomes containing the histone variant H2AZ undergo sliding during mitosis from 
the +1 nucleosomal position to directly cover the TSS, which may be related to the 
bookmarking of active genes during mitosis (Kelly et al., 2010). Of the wide number of 
histone PTMs that occupy interphase chromatin, only a handful have been tested for 
occupancy on mitotic chromatin (Wang and Higgins, 2013). Moreover, only H3K27ac and 
H2AZ have been profiled for their genome-wide distribution during mitosis. It remains 
unclear whether histone PTMs may function, either independently or in collaboration with 




Roadmap for subsequent chapters 
This thesis aims to identify and characterize the spatial (Chapter 2) and temporal 
(Chapter 3) determinants of transcription factor occupancy. We explore these questions 
for multiple key TFs within the murine erythroid cell system, yet we expect that many of 
these findings and approaches can be generalized and applied to other biological contexts. 
In Chapter 2, we examine the genetic variation between three commonly used 
erythroid cell lines and how we might take advantage of this variation to identify novel 
DNA sequence determinants of transcription factor binding. To delineate determinants of 
in vivo TF binding we introduce an approach that compares ChIP-seq and DNase-seq 
datasets from genetically divergent murine erythroid cell lines. Measuring the impact of 
discriminatory single nucleotide variants on TF ChIP signal intensities enables definition 
at single base resolution of the in vivo binding characteristics of the nuclear factors GATA1, 
TAL1, and CTCF. We further tested the requirements of critical nucleotide positions for 
GATA1 binding by combining CRISPR-Cas9-mediated mutagenesis with ChIP and 
targeted deep sequencing. Finally, we extend our analytical pipeline to identify nearby 
contextual DNA elements that modulate chromatin binding by these three TFs and to 
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define sequences that impact kb-scale chromatin accessibility. Together, our broadly 
applicable method reveals new insights into the genetic basis of TF occupancy and their 
interplay with chromatin features. 
In Chapter 3, we explore the longstanding hypothesis that BRD4 operates as a 
mitotic bookmarking TF while also exploring whether histone PTMs might have a role in 
mitotic bookmarking. Genome-wide location analysis of BRD4, combined with novel data 
normalization and peak characterization approaches, reveals that during mitosis, BRD4 is 
preferentially enriched at erythroid-specific genes in the G1E-ER4 erythroid cell line. 
However, transient removal of BRD4 from mitotic chromatin does not impair post-mitotic 
reactivation of transcription. Additionally, histone mass spectrometry reveals global 
preservation of most PTMs during mitosis. Using genome wide profiling, we find that 
H3K14ac, H3K122ac, and H4K16ac predict BRD4 and Pol II mitotic binding and are 
preferentially enriched at erythroid-specific genes during mitosis, suggestive of mitotic 
bookmarking. Together this suggests that BRD4 is not a mitotic bookmark in erythroid 
cells but only a “passenger”. Instead, mitotic histone acetylation patterns may constitute 
the actual bookmarks that promote the faithful restoration of transcriptional patterns after 
mitosis. 
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Finally, Chapter 4 will provide a discussion that summarizes this work and places 
it within the larger field of transcription factors and mitotic bookmarking. We will also 
consider which questions remain unanswered and might be important next steps to 
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In this chapter, we explore the use of genetic variation between erythroid cell lines 
to uncover novel insights about the DNA sequence determinants of TF binding to 
chromatin. While the majority of ENCODE cell lines lack whole genome sequencing, we 
find that “input” ChIP-seq data can be exploited to sensitively and accurately identify sites 
of natural genetic variation. We subsequently use this variation as a tool to better 
understand the in vivo binding determinants of the major erythroid TFs GATA1 and TAL1, 
and the chromatin architectural protein CTCF. Specifically, our approach defines 
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sequence motifs that these TFs contact within chromatin and identifies nearby contextual 
DNA elements and their associated proteins that positively or negatively impact TF 
chromatin occupancy. We then complement this approach by generating a spectrum of 
mutations in select regions followed by ChIP and massively parallel sequencing. By 
developing and integrating these experimental and analytical approaches, we create a 
flexible framework for interrogating the precise sequence determinants of TF binding. 
Moreover, we identify genetic variants that alter chromatin accessibility as a result of TF 
binding site disruption. Collectively, we describe a practical approach to mine data sets for 
both natural genetic variation and TF binding profiles in order to define how transcription 
factors bind and regulate chromatin. 
2.1 Existing ChIP-seq data reveal extensive genetic variation between 
phenotypically similar murine erythroid cell lines 
G1E-ER4 and MEL are cell lines commonly used, in combination with primary 
erythroblasts, for studying erythroid differentiation. These cells can be induced to 
differentiate, upon which broadly similar sets of genes are induced or repressed when 
compared to primary murine erythroblasts (Pishesha et al., 2014; Welch et al., 2004) 
(Spearman r = 0.56-0.72, Appendix Fig. A.1 and Appendix Fig. A.2). A comparison 
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between these cell types revealed strong positive correlations in peak binding intensities 
of two major hematopoietic transcription factors GATA1 and TAL1, as well as in DNase I 
accessibility, reflecting similar regulatory landscapes (Fig. 1a). CTCF, a ubiquitously 
expressed factor with roles in chromatin architecture, also exhibited highly correlated 
peak binding intensities among red cell types (Fig.1a). Cross-comparisons of CTCF 
binding profiles between tissues showed remarkably correlated binding patterns, likely 
reflecting the tissue invariant fraction of CTCF binding sites. Notably, erythroid tissues are 
more correlated in CTCF binding profiles to each other than to other tissues (Fig 1b), 
consistent with patterns comprising both tissue-restricted and tissue-invariant binding 
sites. 
Despite their phenotypic similarity, each of the three erythroid cell types originated 
from a different inbred mouse strain (Pevny et al., 1991; Singer et al., 1974; Weiss et al., 
1997) leading to the expectation that they harbor discriminatory genetic variants that 
might impact chromatin characteristics. Since these cell lines lack whole genome 
sequencing data, we mined ChIP-seq input datasets available from ENCODE (Appendix 
Fig. A.3) to identify such variants relative to the C57BL/6J reference genome build 
(Depristo et al., 2011) (Appendix Fig. A.4a). For primary erythroblasts, since relatively few 
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ChIP-seq data sets are accompanied by sequencing of unprecipitated “input” material, we 
additionally used the background reads from the immunoprecipitated material (excluding 
GATA1/TAL1/CTCF ChIP data) for variant identification. We adapted the GATK 
HaplotypeCaller tool (Depristo et al., 2011) for variant identification, applying stringent 
criteria (detailed in Methods) for assigning mutation zygosity. We benchmarked the 
sensitivity and accuracy of this approach by first using ENCODE input ChIP-seq data to 
call genetic variants in the GM12878 human lymphoblastoid cell line relative to the Hg19 
genome assembly, and then by comparing called variants to the recently sequenced 
GM12878 genome (Zook et al., 2014, 2016). Homozygous genetic variation was identified 
with nearly 100% precision (% of identified variants that are true variants) and with >50% 
recall (% of true variants that are identified) (Fig. 1c). Since variant identification for the 
GM12878 cell line benefits from an unusually large number of input ChIP-seq files 
available from ENCODE (57 files resulting in 1.4 billion unique reads), we examined 
whether fewer input data sets would permit variant identification. We found that 
randomly downsampling the number of GM12878 reads to the numbers available for the 
murine erythroid cell lines still identified homozygous genetic variation with nearly 100% 
precision and ~50% recall (Fig. 1c). We conclude that input ChIP-seq files enable stringent 
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variant identification comprising at least half of existing genome-wide variation in 
ENCODE murine erythroid cell lines. 
Applying these methods to the three murine erythroid cell models identified 
between 1.7-2.6 million homozygous variants (relative to the reference mm9 genome) 
from input ChIP-seq data alone. Additionally, the G1E-ER4 and MEL cell lines are derived 
from mouse strains that have been sequenced by the Sanger Institute Mouse Genomes 
Project (Keane et al., 2011). Merging the variant calls from input ChIP-seq data and those 
made by the Sanger Institute confirms that we can use input ChIP-seq files alone to detect 
41-47% of total genetic variation. Of note, 4-6% of variants present in the erythroid cell 
lines are not found in their parent mouse strains (Appendix Fig. A.4b), suggesting that 
they arose during prolonged culture. In total, these data reveal that each pair of cell line 
genomes is discriminated by 3.9-5.5 million SNPs (discSNPs) (Fig. 1d). Together, 
identification of SNPs directly from ChIP-seq data and from whole genome sequencing 
data (when available) serve as complementary approaches that make discriminatory 




Figure 1 - Control ChIP-seq data reveals extensive genetic variation between functionally 
equivalent ENCODE cell lines.  
(a) Pearson correlation coefficient (PCC) of TF binding and DNase hypersensitivity profiles between pairs of 
erythroid cell lines (E = Erythroblast, G = G1E-ER4, M = MEL) at commonly called peaks. PCC +/- 95% CI. 
(b) PCC of CTCF binding between indicated tissues and erythroid tissues (G1E, G1E-ER4, MEL). Mean +/- 
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SEM, number of comparisons listed in legend. (c) Precision and recall of using input ChIP-seq data in 
GM12878 cells to identify homozygous variants relative to the hg19 reference genome. Vertical lines denote 
the number of input ChIP-seq reads available for the murine erythroid cell lines. (d) Number of discriminatory 
SNP (discSNP) variants between each pair of erythroid cell lines. (e) Median percent signal loss (relative to 
stronger binding signal) at TF peaks or DNase Hypersensitivity (DHS) peaks between erythroid cell lines, 
separated by the number of discSNPs located within the TF/DHS peak. DNase percentages are normalized to 
the 0 discSNP data point within peaks of identical length. *Wilcoxon p < 0.05 for comparison to peaks lacking 
discSNPs. (f) Schematic of the overall analysis approach that uses genetic variants to probe determinants of 
TF binding and chromatin accessibility. 
Importantly, we find a nearly monotonic increase in relative loss (read count 
intensity in weaker allele relative to stronger allele) of either TF binding (GATA1, TAL1, or 
CTCF) or chromatin accessibility as the number of discSNPs located within the peak 
increases (Fig. 1e). These findings suggest that a subset of discSNPs alters otherwise 
similar chromatin features between these murine erythroid cell lines. We thus sought to 
exploit these discSNPs in a comparative analysis of existing ChIP-seq and DNase-seq data 
in order to identify genetic determinants of the transcription factor occupancy and 
chromatin accessibility landscape in erythroid cells (Fig. 1f). 
2.2 Isolated genetic variants within GATA1 binding sites co-occur with 
dramatic alterations in GATA1 binding and nearby transcription 
Upon intersecting the ~15 million discSNPs in erythroid cells with GATA1 
chromatin occupancy data in these cells, we found that 38,594 discSNPs fall within a 
region identified as a GATA1 peak in at least one erythroid cell line (Fig. 2a). We 
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hypothesized that isolated genetic variants (no other variants within 1 kb) within GATA1 
peaks may either directly or indirectly interfere with GATA1 chromatin occupancy. Indeed, 
we find single nucleotide discSNPs associated with dramatic changes in GATA1 binding, 
both when directly impacting or when immediately adjacent to the GATA1 motif (Fig. 2b). 
GATA1 ChIP-qPCR in differentiated G1E-ER4 and MEL cells confirm complete loss of 
GATA1 binding at several sites containing a single isolated discSNP (Appendix Fig. A.5a). 
In some instances, these variants are associated with large corresponding changes in 
proximal gene transcription (Appendix Fig. A.5b).  
For four discSNPs falling within GATA1 motifs, we tested whether they were causal 
in altering GATA1 binding. We tested the effect of isolated discSNPs on GATA1 binding by 
cloning both the G1E-ER4 and MEL alleles for these discSNPs into a retroviral vector that 
randomly inserts the cloned element along with a barcode into the G1E-ER4 genome. 
GATA1 ChIP-qPCR at these ectopic sites recapitulated the allele-specific differences in 
binding seen at endogenous loci (Fig. 2c). The effect size of the SNP on binding was smaller 
at the ectopic sites, possibly due to a tendency of retrovirus to integrate into open 
chromatin whereas the endogenous sites devoid of GATA1 binding can lose chromatin 
accessibility (see below).  
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In order to validate causality of a disruptive SNP on transcription we initially 
attempted homologous recombination (HR) driven CRISPR/Cas9 driven point 
mutagenesis. However, the efficiency of this process in MEL cells was too low (not shown), 
prompting us to instead generate deletions at a relevant discSNP and measure the effect 
on GATA1 binding and local gene transcription. The Bola1 gene TSS is 700 bp downstream 
of a GATA1 peak that contains a single G1E-ER4 discSNP predicted to disrupt a GATA1 
motif. This genetic change is associated with significantly reduced GATA1 binding (q = 
0.024) and Bola1 transcription (q = 0.005) in G1E-ER4 cells (Appendix Fig. A.6a). We find 
that multiple MEL clones containing bi-allelic Cas9-generated deletions (4 – 22 bp) of the 
discSNP region (Appendix Fig. A.6b) exhibit minimal GATA1 binding and diminished 




Figure 2 - Isolated genetic variants within GATA1 peaks co-occur with dramatic changes in 
GATA1 binding and nearby transcription.  
(a) Summary of discSNP pairs in GATA1 peaks. (b) GATA1 ChIP-seq intensity tracks (input and library size 
normalized, identical y-axis scales) reveal dramatic changes in GATA1 binding associated with single 
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nucleotide variants adjacent to or within a GATA1 motif (no other discSNPs within 1 kb). Dotted vertical line 
indicates discSNP position. (c) GATA1 ChIP-qPCR at native (N) loci in either G1E-ER4 or MEL cells where 
one cell line contains an intact (I) GATA1 motif and the other cell line has a disrupted (D) motif.  A 200-bp 
region centered on these intact/disrupted motifs was barcoded and cloned into ectopic (E) locations in G1E-
ER4 cells and GATA1 ChIP-qPCR was performed at these sites. (d) GATA1 ChIP-qPCR and (e) RT-qPCR in 
MEL clones edited at a control locus (WT) or at the Bola1-proximal GATA1 peak. (f) For discSNPs found in 
TSS-proximal GATA1 peaks, Pearson correlation coefficients between delta GATA1 binding and delta 
transcription at a range of FDR cutoffs for differential binding. (g) Scatterplot of delta GATA1 binding vs delta 
transcription at an FDR cutoff of 1e-4, PCC = 0.43. (h) Pearson correlation coefficients between delta GATA1 
binding and delta transcription at a range of cutoffs for distance between the GATA1 peak and nearby TSS. 
For (f) - (h), error bars are 95% confidence intervals, * p = 0.03, ** p < 0.001 (Fisher’s z-transform). 
directly impact GATA1 chromatin occupancy and nearby gene transcription. Moreover, a 
small deletion adjacent to but not overlapping the GATA1 motif, as is the case for clone 2, 
can have equally deleterious effects to deletions of the GATA1 motif, highlighting the 
importance of sequence context in chromatin occupancy (see below).  
GATA1 has been previously shown to mediate widespread gene regulation during 
terminal erythroid differentiation (Cheng et al., 2009; Stonestrom et al., 2015; Welch et 
al., 2004). We thus tested whether discSNPs that alter GATA1 binding impact nearby gene 
transcription on a genome-wide scale. In GATA1 peaks containing at least one discSNP, 
there is a positive correlation between changes in GATA1 binding and in nearby gene 
transcription; this correlation becomes stronger as the FDR threshold for differential 
binding (Benjamini-Hochberg corrected, using DiffBind (Stark and Brown, 2011)) is 
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increased (at FDR 1e-4, Pearson Correlation Coefficient = 0.43, p = 8e-14) (Fig. 2f, g). 
GATA1 binding and transcriptional changes become less correlated with increasing 
GATA1 peak-to-TSS distances, suggesting that GATA1 binding is more likely to regulate 
transcription of the nearest gene at shorter distances (Fig. 2h). These associations might 
underestimate the impact of discSNPs on transcription since proximity is an imperfect 
means of pairing regulatory elements with their target genes. Together these data suggest 
that discSNPs can causally underlie changes in GATA1 chromatin occupancy and 
transcriptional regulation. 
2.3 Genetic variation uncovers single nucleotide resolution determinants of 
GATA1 binding in vivo 
We examined the genome-wide impact of discSNPs on GATA1 binding as an 
unbiased means for defining in vivo genetic determinants of GATA1 chromatin occupancy. 
We used the MEME suite (Grant et al., 2011) and CIS-BP motif database (Weirauch et al., 
2014) to identify discSNP pairs that fall within a TF motif and are predicted to disrupt 
binding to that motif (detailed in Chapter 2.7). We find that 67% of all discSNPs in GATA1 
peaks disrupt a TF motif, with the majority being non-GATA motifs (Fig. 2a). GATA1 is 
the primary GATA factor in differentiated erythroid cells (Doré et al., 2012; Suzuki et al., 
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2013) and it binds to sequences described in the CIS-BP database as GATA1/2/4/6 motifs 
that we collectively treat as the GATA family motif (WGATAR) (Appendix Fig. A.7). We 
use the 1,844 discSNPs disrupting a GATA motif and measure their impact on GATA1 
chromatin occupancy. Our analysis compares normalized GATA1 signal intensity in the 
allele with a disrupted motif relative to the allele with an intact motif (% of GATA1 binding) 
and uses non-parametric statistical methods and permutation-based corrections for 
multiple hypothesis testing to identify nucleotides that significantly contribute to GATA1 
binding (detailed in Chapter 2.7). Indeed, we find that disruption of any nucleotide in the 
WGATAR consensus sequence results in a statistically significant loss of GATA1 binding 
(Fig. 3a). Importantly, although the relative expression levels of signature erythroid genes 
(Pishesha et al., 2014) suggest that primary erythroblasts are slightly more differentiated 
than G1E-ER4 and MEL (Appendix Fig. A.2), the effects of a mutated GATA motif on 
GATA1 binding are consistent regardless of which pair of erythroid cell lines is compared 
(Appendix Fig. A.8). These data indicate that differential GATA1 binding associated with 
genetic variation does not reflect differences in trans factor environment. 
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Figure 3 - Genetic variation reveals sequences that directly regulate GATA1 chromatin 
occupancy.  
(a) Sequence logo reflecting canonical GATA1 motif and the percent impact on GATA1 binding intensity 
associated with discSNPs at various positions and to particular alternative nucleotides. (b) Normalized read 
count in sequenced ChIP Input vs GATA1 IP for deletion-containing alleles of the Bola1-proximal GATA1 peak 
in MEL cells. Gray points indicate deletions removed due to low Input read counts, red points indicate 
deletions above the read count threshold, blue point indicates wild type (non-deleted) MEL allele. Solid line 
indicates 1:1 normalized IP enrichment, dashed lines indicate 10-fold changes in enrichment. (c) Aggregate 
effects on GATA1 IP enrichment of either full or partial deletions of the WGATAR motif or of deletions not 
overlapping this motif, mean +/- SEM. (d) Aggregate effects of 1- or 2-bp deletions within a 2-bp sliding 
window across the GATA1 motif on GATA1 IP enrichment, mean +/- SEM. 
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Evidence from PCR-mediated site selection, EMSA, and ChIP-seq experiments 
suggests that the central GATA nucleotides are required for in vitro GATA1 binding (Ko 
and Engel, 1993; Merika and Orkin, 1993) and are found with near 100% frequency in the 
in vivo GATA1 binding motif (Fujiwara et al., 2009; Yu et al., 2009). We find, however, 
that these core motif nucleotides contribute unequally to GATA1 binding in vivo and that 
the prevalence of a nucleotide at a given position within the GATA motif does not always 
correlate with its contribution to in vivo binding. For example, while in vitro SELEX 
experiments suggest that the G is more essential to binding than the first A, we find that 
disruption of the G results in a milder effect on in vivo GATA1 binding (29% ChIP signal 
loss) than disruption of the A (49% ChIP signal loss, Wilcoxon p = 0.004). These data 
suggest that in vivo TF-chromatin interactions are not identical to in vitro TF-DNA 
oligonucleotide interactions and are modulated by factor or chromatin context. 
Additionally, we identify nucleotide substitutions that strongly impair GATA1 binding in 
a manner dependent on the type of substitution (Fig. 3a). Together, these results provide 
a framework for understanding the quantitative impact of any substitution within the 
GATA1 motif on in vivo GATA1 chromatin occupancy. 
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In order to directly test the causality of select discSNPs on GATA1 DNA binding we 
attempted to carry out homologous recombination directed CRISPR-Cas9 mediated 
mutagenesis but found this process to be of very low efficiency in our erythroid cell lines. 
Instead, to experimentally test endogenous GATA1 binding preferences, we developed an 
approach that combines CRISPR/Cas9, conventional GATA1 ChIP, and targeted deep 
sequencing to interrogate GATA1 binding determinants in a high-throughput and high-
resolution manner. As before, we targeted the Bola1-proximal GATA1 peak in MEL cells 
using a gRNA designed to cleave within the GATA1 consensus motif. Deep sequencing of 
genomic DNA from edited MEL cells reveals a diverse range of deletions averaging 26 bp 
long; 50% of these completely delete the WGATAR sequence and 41% partially delete this 
sequence (Appendix Fig. A.9). We performed GATA1 ChIP on these cells followed by 
targeted deep sequencing of both ChIP input and IP material, and found a large number 
of deletions that are depleted in the IP library relative to their starting abundance (Fig. 
3b). GATA1 binding is substantially reduced by both full and partial deletions of the 
GATA1 motif (Fig. 3c). Surprisingly, GATA1 binding is similarly diminished by deletions 
adjacent to but not containing the GATA1 motif, implicating nearby non-WGATAR 
sequences in regulating GATA1 binding (see below). We next used a 2-bp sliding window 
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to analyze the effects of 1- and 2-bp long deletions within the GATA1 WGATAR motif. We 
find similar nucleotide sensitivities (Fig. 3d) as determined by genome-wide discSNPs 
(Fig. 3a), suggesting that discSNPs within the GATA1 motif reveal causal nucleotide 
determinants of in vivo GATA1 chromatin occupancy. We envision that this method can 
be extended to single nucleotide resolution by use of additional guide RNAs and deeper 
sequencing. Together, these discSNP- and CRISPR-Cas9- mediated approaches enable 
definition of in vivo GATA1 DNA binding determinants at base pair level resolution. 
2.4 Genetic variation in nearby contextual sequences regulates GATA1 
binding 
We next turned our focus to the 24,039 discSNPs located in GATA1 peaks that alter 
a non-GATA motif as a means for identifying potential genetic and protein regulators of 
GATA1 chromatin occupancy. While both in vitro (Merika and Orkin, 1995; Osada et al., 
1995) and in vivo (Han et al., 2016; Tripic et al., 2009; Ulirsch et al., 2014) studies have 
identified proteins likely to interact with GATA1 in transcriptional regulation, little is 
known about how these proteins impact GATA1 chromatin occupancy on a genome-wide 
scale. Of note, it has not been established whether the DNA-binding activity of other TFs 
that that physically interact with GATA1, such as TAL1 or NFE2, impacts GATA1 binding 
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in a similarly collaborative fashion. In fact, analysis of discSNPs disrupting non-GATA TF 
motifs reveals multiple DNA sequences with significant (q < 0.1) positive contributions to 
GATA1 binding (Fig. 4a). Additional motifs, including those associated with proteins 
previously shown to interact with GATA1, have less significant median effects on GATA1 
binding. DiscSNPs that disrupt the KLF1 motif, for example, have in some cases dramatic 
effects on GATA1 binding but in the majority of cases relatively little effect, likely due to 
the low genome-wide co-localization of KLF1 and GATA1 (Pilon et al., 2011) and the impact 
of contextual constraints such as motif spacing and orientation. Strikingly, we find that 
the disruptive effect of a discSNPs within a GATA motif deteriorates as the number of 
adjacent TF binding sites (non-GATA motifs that promote GATA1 binding) increases (Fig. 
4b). We also find that discSNPs disrupting either a GATA motif or a proximal contextual 
motif have markedly stronger effects in ablating GATA1 binding as the predicted binding 
affinity (based on MEME score) of the disrupted motif increases (Appendix Fig. A.10). 
These data directly implicate proximal contextual motifs as a mechanism to buffer in vivo 
GATA1 binding against motif mutations that would severely impact binding in vitro. 
Despite extensive in vitro and in vivo studies that identified motifs for GATA1 and 
other TFs, prediction of genome-wide binding of these factors has been limited by a lack 
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of consideration of genomic context. While predictions have been substantially improved 
by the integration of chromatin features such as accessibility (Maurano et al., 2015; Pique-
Regi et al., 2011) or histone marks (Kumar and Bucher, 2016; Talebzadeh and Zare-
Mirakabad, 2014), these data are not always available, and it remains unclear how to 
accurately predict TF binding to a genomic region from DNA sequence alone. To this end, 
we hypothesized that nearby genetic sequences that regulate GATA1 binding may better 
predict whether GATA1 binds to its canonical motif. We trained a logistic regression model 
for the genome-wide prediction of GATA1 binding that incorporates as features both the 
GATA motif match score and match scores for each contextual motif found within 100 bp 
of the GATA motif. A model that considers not only GATA motif matching but nearby motif 
matches to 7 other TFs (HIVEP1, KLF1, NFE2, NFE2L2, TAL1, composite GATA-TAL1, 
TCF12) significantly outperforms (p=9e-13) both a model that only considers GATA and a 
control model that considers GATA along with randomly shuffled versions of these 7 
motifs (Fig. 4c). At a false discovery rate (FDR) of 0.3, this results in an increase from 34% 
to 57% of true GATA1 peaks that are correctly identified when considering potential 
binding of nearby contextual factors (Appendix Fig. A.11). We were limited in making this 
comparison between prediction models at FDR values less than 0.25 since the GATA motif 
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only model has a sensitivity of 0% at these values. These data illustrate the need to 
consider nearby contextual regulatory sequences when evaluating TF binding. 
We limited our analysis to DNA motifs whose corresponding TFs are expressed in 
erythroid cells (Appendix Fig. A.12a). However, we find that a number of these motifs have 
highly similar sequences (Appendix Fig. A.12b), and thus the TF protein binding these 
sequences cannot be unambiguously assigned. To better understand the proteins that 
regulate GATA1 binding, we exploited existing erythroid ChIP-seq data for TAL1, ELF1, 
and TCF12 to test whether binding by these proteins reflects the impact of discSNPs on 
their corresponding DNA motifs. DiscSNPs that disrupt motifs for TAL1 and ELF1 in 
GATA1 peaks are associated with concomitant loss of TAL1 and ELF1 protein at these 
locations, while disruption of TCF12 motifs have relatively little effect on TCF12 occupancy 
(Fig. 4d). This implicates 
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Figure 4 - Genetic variation in nearby contextual sequences regulates GATA1 binding. 
(a) TFs whose motifs significantly alter GATA1 binding (% impact, median +/- 95% CI) when disrupted by a 
discSNP. Vertical line indicates no effect, color indicates significance level. (b) DiscSNPs that directly disrupt 
a GATA motif have variable impacts on GATA1 binding depending on the number of positive co-regulatory 
motifs (from panel b) found within 100 bp of the discSNP. Wilcoxon, * p = 0.02, ** p < 0.0004. (c) ROC curves 
comparing logistic regression models that predict GATA1 binding based on either the GATA1 motif alone 
(PWM only), a combination of the GATA1 motif and nearby contextual regulatory motifs (contextual), or a 
control combination of the GATA1 motif and scrambled versions of the contextual motifs (shuffled). ROC 
curves are shown as median of 10 cross-validation runs. AUC is represented in the sub-panel as a boxplot of 
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the 10 cross-validation runs, DeLong's paired test for two correlated ROC curves: *p = 9e-13. (d) Median ChIP-
seq intensity of 3 TFs at their corresponding motifs in either an intact state or disrupted by a discSNP within 
a GATA1 peak. Position is shown relative to the discSNP position (400 bp upstream to 400 bp downstream). 
Significant differential binding (*) was assessed by a BH-corrected t-test in the -200 to + 200 region (TAL1: q 
= 0.008, ELF1: q = 0.008, TCF12: q = 0.25). (e) Sliding bins (10-bp wide, overlapping by 5 bp) test the impact 
of contextual motif disruption on proximal GATA1 binding as a function of relative distance to the nearest 
GATA1 motif. Colors represent significance in altering binding, permutation-adjusted for multiple hypothesis 
testing. (f) Sliding window medians of the impact of NFE2L2 and TAL1 motif disruption on GATA1 binding as 
a function of distance to motif. (g) Sliding window medians of the impact of GATA1 motif disruption on TAL1 
binding as a function of distance to the nearest TAL1 motif. 
TAL1 and ELF1 but not TCF12 as candidate factors that promote GATA1 binding on a 
genome-wide scale, while the effects seen by TCF12 likely instead result from E2A, an 
obligate heterodimer of TAL1 (Hsu et al., 1994) that binds a highly similar TF motif to 
TCF12 (Appendix Fig. A.12b). 
Transcription factor motif spacing has been previously shown to provide strict 
constraints on collaborative binding (Panne et al., 2007) and enhancer function (Narlikar 
et al., 2010; Swanson et al., 2010). For example, GATA1 has been shown to frequently bind 
adjacent GATA and E-box DNA motifs spaced between 8-10 bp apart (Li et al., 2013; Ng 
et al., 2014), and reporter assays find this particular spacing to be critical for the activity 
(Senger et al., 2004; Wozniak et al., 2008). Thus, we examined the effect of distance 
between non-GATA motifs that affect GATA1 occupancy that are altered by discSNPs and 
the nearest GATA motif. While for some motifs the data were too sparse for this analysis, 
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we uncovered motifs that regulate GATA1 binding predominantly at short distances (< 30 
bp, TCF12, THRA), or long distances (30-50 bp, SP3, E2F1) (Fig. 4e and Fig. 4f). 
Surprisingly, several motifs, including the E-box commonly bound by TAL1, regulate 
GATA1 binding at a wide range of distances (0-50 bp) that have not have been predicted 
by either motif enrichment analysis or enhancer reporter assays. Similarly, analysis of 
discSNP effects on TAL1 ChIP-seq signal in G1E-ER4 vs primary erythroblasts shows that 
GATA1 motif mutations impact TAL1 binding at distances as great as 75 bp (Fig. 4g), 
supporting previously unappreciated long-range collaborative binding between the 
master erythroid factors GATA1 and TAL1. These data demonstrate that natural genetic 
variation is a sensitive method for uncovering contextual rules that govern in vivo TF 
chromatin occupancy. 
2.5 Both the CTCF motif and nearby contextual motifs shape constitutive 
and erythroid-specific CTCF binding 
Analysis of genetic variation in erythroid cells not only allows us to understand 
how erythroid-specific factors bind chromatin but also how ubiquitously expressed TFs, 
such as CTCF, bind chromatin in a tissue-specific manner. While CTCF binds many 
locations in all cell types, a fraction of its binding sites is dynamic and lineage specific, 
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including in erythroid cells (Chen et al., 2012; Dubois-Chevalier et al., 2014; Wang et al., 
2012) (Fig. 1b). We hypothesized that analysis of discSNPs that disrupt either constitutive 
or erythroid-specific CTCF binding sites might identify determinants of CTCF chromatin 
occupancy that are cell-type-invariant or erythroid-specific, respectively. We find that 
genetic variants disrupting the CTCF motif (1459 discSNPs in 1329 CTCF peaks) reveal 
both the positions critical for in vivo binding and the types of substitutions that are most 
poorly tolerated (Fig. 5a). The three regions most critical for binding (‘CCA’,’AG’,’GGC’) 
are also the most conserved nucleotides at high-occupancy CTCF binding sites 
(Plasschaert et al., 2014) and contain the two nucleotides (2C, 12C) that when methylated 
are associated with decreased CTCF binding (Wang et al., 2012). Notably, these data 
recapitulate in vitro data that 12C ->T significantly diminishes binding (Plasschaert et al., 
2014) and additionally find several other mutations that are even more deleterious to in 
vivo CTCF binding. 
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Figure 5 - Genetic variation between erythroid cell lines reveals genetic regulatory sequences 
directing erythroid-specific CTCF chromatin occupancy.  
(a) Sequence logo reflecting existing CTCF factor motif information and the percent impact on CTCF binding 
intensity associated with mutations at various positions and to particular alternative nucleotides. (b) TFs 
whose motifs significantly alter CTCF binding (% impact, median +/- 95% CI) when disrupted by a discSNP. 
Vertical line indicates no effect, color indicates significance level. (c) The effect of discSNPs that disrupt CTCF 
motifs on CTCF binding at constitutive, erythroid-specific, or erythroid differentiation induced CTCF peaks. 
Percent impact, median +/- 95% CI. * Wilcoxon p = 1e-6, ** p = 1.7e-14, *** p = 4.7e-39. (d) GFI1b and NFE2 
motifs are enriched in erythroid-specific CTCF peaks (foreground) relative to constitutive CTCF peaks 
 47 
(background) both when considering all CTCF peaks and the subset that contain a CTCF-motif discSNP as in 
Fig. 5c. Benjamini-Hochberg q-values: * q = 0.02, ** q = 0.001, *** q = 0.0000. 
We additionally identify several DNA sequences outside of the CTCF core motif 
that may positively or negatively regulate CTCF binding in erythroid cells (Fig. 5b). 
DiscSNPs in the CTCF motif itself have the strongest effects on CTCF binding, while those 
that disrupt other motifs, such as the CTCF-downstream motif (Nakahashi et al., 2013), 
exhibit relatively milder effects, potentially due to constraints such as motif spacing. 
Notably, four of the 18 motifs that regulate CTCF binding correspond to the erythroid 
transcriptional regulators NFE2, TAL1, KLF1, and GFI1b. We hypothesized that these 
factors may be involved in directing erythroid-specific CTCF binding during 
differentiation. Intersection of CTCF peak sets from 23 mouse tissues identified CTCF 
peaks conserved in more than 60% of tissues (constitutive) and those found in fewer than 
20% of tissues (variable). Of the variable peaks, we further identified those found 
specifically in erythroid tissues and those induced upon erythroid cell maturation 
(Appendix Fig. A.13). Stratifying the effects of discSNP mutations to the CTCF motif by 
these groups reveals markedly stronger effects on CTCF binding at sites specific to 
differentiated erythroid cells than at constitutive peaks (Fig. 5c). In addition, erythroid-
specific CTCF peaks are significantly enriched for both NFE2 and GFI1b motifs relative to 
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constitutive CTCF peaks (Fig. 5d). Together, these data suggest that tissue-specific CTCF 
sites are less robust to genetic variation and are sensitive to mutations within either the 
CTCF motif or proximal tissue-specific TF motifs. 
2.6 Distinct DNA motifs promote chromatin accessibility before and after 
erythroblast differentiation 
To identify genetic determinants of chromatin accessibility we examined the 
impact of discSNPs on DNase hypersensitivity (DHS) in undifferentiated and 
differentiated erythroid cells. In agreement with previous reports (Hsiung et al., 2015; 
Kadauke et al., 2012; Wu et al., 2011, 2014) we found that in spite of dramatic changes in 
gene expression during erythroid differentiation, genome-wide chromatin accessibility 
within DNase1 peaks is largely unchanged (Appendix Fig. A.14), suggesting that genome 
accessibility is already mostly established in immature cells. Nevertheless, as the 
transcription factor milieu changes during maturation it is possible that different factors 
are involved in the formation and maintenance of accessible chromatin sites. For example, 
in immature erythroid cells the major GATA binding protein GATA2 might play a role in 
DNase hypersensitive site formation (Wang et al., 2007). In terminally differentiating 
cells, GATA1 replaces GATA2 (Doré et al., 2012; Huang et al., 2016; Suzuki et al., 2013) 
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and might maintain chromatin accessibility or become dispensable for this function (Fig. 
6a). 
We examined in an unbiased manner the impact of all 726 TF motifs in the CIS-
BP motif database (Weirauch et al., 2014) on chromatin in both differentiation states. We 
find that composite GATA-TAL1 motifs have the strongest effects on chromatin 
accessibility genome-wide in immature erythroid cells (Fig. 6b), consistent with a 
requirement for GATA2 in DNase HS formation. In differentiated cells, GATA elements 
are also the most influential on DNase accessibility. However, it is impossible to 
distinguish whether this reflects the failure to establish accessible sites prior to maturation 
(the GATA2hi GATA1low state) or to maintain accessibility in the mature (GATA1hi 
GATA2low) state. Less pronounced effects were seen with DNA motifs bound by 
hematopoietic TFs, such as ETS binding sites (PU.1, EHF, ETV6, ETS1), Krüppel factor 
binding sites (KLF12), and BCL11A (Fig. 6b). It is important to bear in mind that motif 
identification does not definitively reveal the actual trans-acting factor bound to it. 
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Figure 6 - Genetic variation identifies DNA motifs that promote accessible chromatin at TF 
binding sites.  
(a) Model describing the undifferentiated GATA2highGATA1low and the differentiated GATA2lowGATA1high 
erythroid states and the roles these TFs may play in regulating chromatin accessibility. (b) TFs whose motifs 
significantly alter genome-wide DNase peak signal (% impact, median +/- 95% CI) when disrupted by a 
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discSNP in undifferentiated (-GATA1) or differentiated (+GATA1) erythroid cells. Vertical line indicates no 
effect, color indicates significance level. (c) TFs whose motifs significantly alter DNase signal (% impact, 
median +/- 95% CI) at GATA1-regulated promoters or within TF binding peaks when disrupted by a discSNP 
in undifferentiated (-GATA1) or differentiated (+GATA1) erythroid cells. (d) Mean ChIP-seq intensity of 
GATA2 (in undifferentiated erythroid cells) at DNase peaks bound by GATA1 (in differentiated cells) at either 
an intact GATA motif or at one disrupted by a discSNP. Position is shown relative to the discSNP position (-
400 bp upstream to 400 bp downstream). Significant differential binding (*) was assessed by BH-corrected 
Wilcoxon test in the -200 to + 200 region (q = 0.003) (e) Heatmaps showing the intensity of either GATA2 or 
GATA1 binding or DNase hypersensitivity in the undifferentiated (-GATA1) or differentiated (+GATA1) state 
at all sites that GATA1 binds in differentiated cells. Peaks (15,527) were sorted by GATA1 binding intensity in 
the differentiated state, regions span -1kb to + 1kb centered on peak. 
Since GATA1-regulated genes typically have promoters that directly overlap DNase 
peaks, we exploited discSNPs within these overlapping regions to identify genetic 
determinants of chromatin accessibility at the promoters of GATA1-regulated genes. We 
find that mutations to NFE2 motifs significantly reduce TSS-proximal chromatin 
accessibility at genes whose transcription is activated by GATA1 (Fig. 6c). This finding is 
consistent with previous reports that NFE2 and GATA motifs are both required to 
establish accessibility at the beta-globin locus control region (Pomerantz et al., 1998; 
Stamatoyannopoulos et al., 1995). Additionally, we find motifs that mediate either more 
(T, MAFB) or less (HOXB1) accessible chromatin at GATA1-repressed gene promoters 
(Fig. 6c). This finding suggests that GATA1-mediated repression involves a balance 
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between factors that keep chromatin open, potentially to allow access by repressor 
complexes, and factors that promote a closed chromatin state. 
We next examined the genetic requirements for chromatin accessibility specifically 
at GATA1, TAL1, and CTCF occupied sites. We found that the DNA motifs corresponding 
to each of these factors have significant roles in promoting open chromatin at their peak 
locations in both the undifferentiated and differentiated state (Fig. 6c). Additionally, for 
both GATA1 and CTCF, discSNPs within the TF peak impact TF occupancy and chromatin 
accessibility in a highly correlated fashion, and these correlations become stronger at more 
stringent FDR thresholds for differential TF binding (Appendix Fig. A.15). Together, these 
data strongly implicate GATA1/2, TAL1, and CTCF as the relevant proteins that promote 
chromatin accessibility at their respective binding sites. Notably, the KLF12 (highly related 
to KLF1) motif (Appendix Fig. A.12) also promotes open chromatin at GATA1 peaks, 
suggesting that chromatin accessibility at these locations may rely on collaborative TF 
binding (Fig. 6c). 
The finding that GATA motifs promote accessibility at GATA1 peaks even in the 
undifferentiated state suggests that GATA2 may play a role in establishing open chromatin 
at these sites as mentioned above (Fig. 6d). In order to evaluate whether GATA2 may be 
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establishing chromatin accessibility at sites that are later bound by GATA1 in 
differentiated erythroid cells, we examined GATA2 binding in the undifferentiated state 
at these sites. In places where a GATA motif discSNP is associated with a decrease in 
accessibility, we find significant loss of GATA2 binding in the undifferentiated state (Fig. 
6d). More broadly, at all sites bound by GATA1 in differentiated cells, higher levels of 
GATA2 in the undifferentiated state correlate with greater chromatin accessibility in the 
undifferentiated state (r=0.55) (Fig. 6e, Appendix Fig. A.16). Higher GATA2 occupancy in 
the GATA2hi GATA1low undifferentiated state also correlates with greater accessibility 
(r=0.50) and GATA1 occupancy (r=0.48) in differentiated cells (Fig. 6e, Appendix Fig. 
A.16). Together, these data suggest that GATA2 establishes an open chromatin state at 
places later bound by GATA1 binding in differentiated erythroid cells.  
In sum, the analysis outlined here allows identification of DNA elements and in 





Culture of GATA1-containing erythroblast (G1E-ER4) cells has been described 
(Weiss et al., 1997). GATA1 was activated by addition of 100 nM estradiol for 24 hours. 
Culture of murine erythroleukemia (MEL) cells has been described (Reddy and Shen, 
1993). MEL cells were differentiated by addition of 2% DMSO for 48 hours. For ectopic 
retroviral integration experiments, both alleles of a TF binding site containing a discSNP 
were cloned into the MigR1 retroviral vector backbone. Retrovirus was packaged in 293T 
cells and used to infect G1E-ER4 cells. Cells were sorted for high GFP signal and qPCR was 
used to validate the copy number of the ectopic constructs as at least two alleles per cell. 
qPCR was performed with Power SYBR Green (Invitrogen). 
Chromatin immunoprecipitation (ChIP) 
ChIP was performed as previously described (Letting et al., 2004). GATA1 N6 
antibody sc-265 (Santa Cruz) and rat serum IgG I8015 (Sigma-Aldrich) were used at 10 
ug/IP reaction. qPCR primers are listed in Appendix Fig. A.25 for both endogenous sites 
and ectopic site qPCR barcodes. 
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RNA expression analysis 
For RNA qRT-PCR, we isolated RNA using TRizol (Life Technologies). Reverse 
transcriptase reaction was performed using iScript (Bio-Rad). qPCR primers are listed in 
Appendix Fig. A.25. Transcript quantifications are normalized to a panel of reference 
genes (B-actin, Gapdh, Fog1, Gata2, Klf1, Pabpc1, Slc4a1, Spna1) using median CT value 
in order to reduce clonal variability. 
Cas9-mediated DNA editing 
Targeted editing of the Bola1-proximal GATA1 peak was conducted in Cas9+ MEL 
cells. The Cas9 expression vector was derived by inserting the Streptococcus pyogenes 
Cas9 CDS (Addgene: #49535) into a lentiviral EFS-Cas9-P2A-Puro expression vector. This 
Cas9 lentiviral vector was termed LentiV_Cas9_puro. The MEL cells were lentiviral 
tranduced with LentiV_Cas9_puro and selected with 5 ug/ml puromycin for 5 days. These 
MEL-Cas9 cells were then infected with a Lenti-gRNA-GFP (LRG, Addgene: #65656) 
vector containing either the targeting Bola1 gRNA or a control gRNA targeting a GATA1 
peak in the AW011738 gene. To generate clones containing bi-allelic deletions, GFP+ cells 
were sorted into 96-well plates and screened by genomic DNA PCR and Sanger 
Sequencing. High-throughput screening of GATA1 binding required collecting GFP+ cells 
in bulk and performing GATA1 ChIP using this cell population.  
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Deep sequencing of GATA1 binding at the Cas9-targeted Bola1-proximal 
GATA1 peak 
Deep sequencing libraries of the GATA-bound Bola1 promoter region were 
constructed similarly as described previously (Shi et al., 2015). The Bola1 locus from ChIP 
input and GATA1 IP material was PCR amplified such that the wild type sequence would 
yield a 186 bp target amplicon. The PCR product was end-repaired using T4 DNA 
polymerase (NEB), DNA Polymerase I, Large (Klenow) Fragment (NEB) and T4 
polynucleotide kinase (NEB). An A-overhang was then added to 3’ end using Klenow 
Fragment (3'-5' exo-) (NEB). Finally, the DNA fragment was ligated with custom barcodes, 
and PCR-amplified with Illumina paired-end sequencing primers (Shi et al., 2015). 
Library size was determined (average ~470 bp) using the Agilent Bioanalyzer 2100, 
followed by quantitation using real-time PCR using the KAPA Library Quant Kit for 
Illumina (KAPA Biosystems catalog no. KK4835). Paired-end sequenced (2 x 150 bp) was 
performed on the Illumina NextSeq 500 in the high output mode using Illumina 
sequencing reagents according to manufacturer’s instructions, and bcl2fastq2 v2.15.0.4 
was used to convert the reads to fastq using default parameters. Read pairs were merged 
into a single sequence using Flash (Magoč and Salzberg, 2011) (v1.2.11, parameters: -M 
125 –m 4) and aligned to the wild type sequence using Needle (Rice et al., 2000) (v6.6.0, 
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parameters: -gapopen=10 -gapextend=0.5 -awidth3=5000). Each sample had between 68 
and 76 million read pairs with > 80% identity to the WT sequence that either matched the 
WT sequence or had a single deletion. Read counts for a particular deletion-containing 
allele were normalized by the WT allele read counts for that replicate such that the WT 
allele enrichment ratio (IP read count /Input read count) = 1. For Fig. 3d, enrichment 
ratios for 1- or 2-bp deletions were aggregated into sliding windows and tested for 
enrichment less than 1 using Wilcoxon tests. 
Evaluating similarity between cell lines 
To evaluate similarity in transcriptional profiles, ENCODE tsv gene count files 
were obtained that corresponded to multiple replicates of RNA-seq data in differentiated 
G1E-ER4, MEL, and primary erythroblasts. After removal of ERCC spike-ins and non-
ENSMUSG genes, genes were limited to those with minimum expected count of 35 in two 
replicates (reducing gene count from 30,000 to 12,000). We then used voom-limma 
(Ritchie et al., 2015) for differential expression analysis between pairs of cell lines. This 
involved TMM normalization using edgeR (v3.16.5, default parameters) followed by 
limma/voom (v3.30.8, default parameters) for data fitting and determining differentially 
expressed genes. 
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To evaluate similarity in TF binding, aligned ChIP-seq reads and the associated 
peak calls were obtained from ENCODE. We used DiffBind (Stark and Brown, 2011) (v3.6, 
parameters: minOverlap 1, summits 100, bRemoveDuplicates=T) to generate input- and 
library size-normalized binding intensities for each TF at the intersection of called peaks. 
We then computed Pearson correlations between peak signal intensities. Pearson 
correlation confidence intervals and differential comparisons are given based on Fisher’s 
Z transform. For Fig 1e, differential TF binding was defined as FDR (from DiffBind) < 
0.05. 
To evaluate similarity in DNase hypersensitivity, aligned DNase-seq reads and the 
associated hotspot peak calls were obtained from ENCODE. Peak signal intensities were 
obtained at these peaks, library-size-normalized, and correlated between cell types using 
Pearson correlation. For Fig 1e, differential DNase peaks were defined as FDR (Benjamini-
Hochberg corrected t-test p-values) < 0.05. For this analysis, data were grouped by 
hotspot size (since discSNP count/hotspot correlates with hotspot length) and the % of 
peaks with differential DNase signal was determined relative to peaks of that length 
containing no discSNPs. 
These merged peak locations were later used as consensus locations for discSNP analysis. 
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Calling genetic variation from input ChIP-seq data 
Input ChIP-seq fastq files were obtained from ENCODE for each cell line analyzed. 
We used Trim Galore! (Krueger, 2012) (v0.4.1, parameters: phred33, -quality 20) to 
remove adapters and low quality reads (ends < 20 bp; read length < 20 bp) and then bwa 
(Li and Durbin, 2009) (v0.7.5a-r405, default parameters) to align these reads to the mm9 
or hg19 genome builds. Picard (Broad Institute) (v1.121,default parameters) was applied 
to assign read groups and discard unmapped reads. We used multiple functions from 
GATK (Depristo et al., 2011) (v3.3, parameters: - variant_index_type LINEAR –
variant_index_parameter 128000 –emitRefConfidence GVCF –T Haplotype Caller –
genotyping_mode DISCOVERY – stand_emit_conf 10 –stand_call_conf 30) to identify 
variant nucleotide positions and the number of reference/variant reads found at these 
positions across all fastq files. We only considered variants with a total read depth > 5. 
Variants were called as homozygous reference if they either had fewer than 9 total reads 
and 0 variant reads, or if they had at least 11 total reads and fewer than 5% variant reads. 
Alternatively, variants were defined as homozygous variants if they had at least 11 total 
reads and greater than 90% variant reads. 
Following these assignments, DNAcopy (Olshen et al., 2004) (v1.44.0, default 
parameters) was used to identify blocks of the genome containing at least ten variant calls 
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where at least 90% of the calls share a zygosity of homozygous variant. Calls in these blocks 
that could not be assigned an accurate zygosity based on the procedures above (usually 
due to low read depth) were assigned the zygosity of their surrounding block. 
For all comparisons of variants between erythroid cell lines, we considered only 
loci where one cell line contained a homozygous variant and a different cell line was 
homozygous reference. 
Benchmarking methods for calling genetic variation on the GM12878 
genome 
Homozygous variants were called for the GM12878 (NA12878) cell line as 
described above. These variants were benchmarked against a set of gold standard 
homozygous variant calls identified by the Genome in a Bottle (GIAB) Consortium’s 
whole-genome sequencing of GM12878 cells (Zook et al., 2014, 2016). Regions in the GIAB 
vcf file that fall within repeats or containing multiple alternative alleles were excluded 
from the gold standard set. This resulted in a gold standard set consisting of 1099780 SNPs 
and 136109 indels. The homozygous reference gold standard calls are the 961615 positions 
called by GATK as variant in at least one ChIP-seq dataset but not listed as variant in the 
GIAB vcf file. Evaluation of performance at lower starting read counts was performed by 
random downsampling of the 59 fastq files available for GM12878 into sets of either 50, 
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40, 30, 20, 15, 10, 8, 6, or 4 fastq files that were used as the input for our variant calling 
pipeline. 
Transcription factor motif calling 
Motif scanning was completed by using the MEME suite (Grant et al., 2011) fimo 
tool (v4.11.1, default parameters, uniform background) and CIS-BP motif database 
(Weirauch et al., 2014) plus five additional motifs (GATA1-double, joint TAL1-GATA1, 
TAL1 alone, CTCF upstream/downstream). Motif hits for all GATA family motifs 
(Gata1/2/3/4/6) were merged as GATA1 motifs. The full set of motifs (726) was used for 
analysis of DNase data, while only motifs corresponding to TFs expressed in erythroid cells 
(175) were used for analysis of TF binding. For Fig. 5d, differential motif enrichment was 
performed using HOMER’s findMotifs tool (Heinz et al., 2010) (v4.9, default parameters) 
using the same motif database as above. 
DiscSNPs that fell within TF binding peaks or DNase sites were tested for whether 
they disrupted a TF DNA motif as follows. A 40-bp window centered on the discSNP was 
scanned for motifs in order to find all motifs that contained the discSNP. The highest 
MEME-score position for any given motif-discSNP pair was determined and the MEME 
score for this motif in that exact position was collected for both alleles. For that discSNP 
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pair, the highest MEME score was called the Scoremax and the difference between MEME 
scores was called the DiffScore. 
We used a random walk optimization approach to determine thresholds to call a 
motif as a true predicted binding site (Scorethres) and to call a motif as disrupted by a 
discSNP (DiffScorethres). Values for these thresholds were randomly initialized and 
iteratively trained on all discSNPs that disrupt motifs for GATA1, TAL1, or CTCF. The 
impact of disruptions to these motifs on ChIP-seq binding intensity for their respective TF 
was optimized over 100 runs using 10x cross validation. We find nearly optimal 
performance for each TF with Scorethres = 7.5 and DiffScorethres = 2.5. We subsequently 
applied these thresholds to all motif scanning. 
Associating motif disruption with differential TF binding and chromatin 
accessibility 
DiscSNPs predicted to disrupt TF occupancy on a DNA motif were categorized by 
either TF motif, position within the motif, or identity of the variant nucleotide. ChIP-seq 
TF binding intensity was input-subtracted and library-size normalized using DiffBind 
(Stark and Brown, 2011). DNase intensity was library-size normalized and signal 
distributions were quantile normalized. These normalized ChIP-seq and DNase-seq 
intensities were compared between the alleles contained the intact vs disrupted motifs to 
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identify the percent residual binding/accessibility intensity on the allele with motif 
disruption. Wilcoxon tests were performed to determine if the percent residual intensity 
differed from 100%. Bootstrapping methods were used to generate 95% confidence 
intervals by randomly sampling with replacement for 1000 runs and median effect values 
for runs in the 2.5% and 97.5% percentiles. Multiple hypothesis testing between 
dependent tests was done by randomly permuting test group labels and using the p-value 
of the most significant (smallest p-value) Wilcoxon test across 1000 runs to generate a null 
distribution, from which a q-value reflects how many of these null p-values are smaller 
than the actual test p-value in question (Sham and Purcell, 2014). Identification of 
distance constraints on motif disruption (Fig. 4) was done by subsetting data into 10-bp 
sliding bins from a distance of 0 bp to 100 bp, overlapping by 5 bp. Multiple testing 
correction was done for these 20 bins for any given factor using permutation-based 
methods as described above. 
Prediction of GATA1 binding sites 
Genome-wide GATA1 motif hits were determined by using the GATA1 position-
specific weight matrix (PWM) and MEME’s fimo tool (Grant et al., 2011) (v4.11.1, default 
parameters, uniform background). From these hits, a set of 27,272 positive GATA1 binding 
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sites was constructed by filtering for hits in called GATA1 peaks (ENCFF001YFS). A set of 
27,272 mono- and di-nucleotide composition-matched negative GATA1 binding sites was 
constructed using MEME hits outside of GATA1 peaks for which normalized GATA1 IP 
read counts (ENCFF001MRW and ENCFF001MRR) are no more than the input 
normalized read counts (ENCFF001MSP and ENCFF001MSK) inside a 400 bp window 
centered on the motif match. Read counts were extracted in motif match regions using 
BedTools multiBamCov (Quinlan and Hall, 2010) (v2.240, default parameters) and 
normalized using mapped read totals over all 400 bp windows produced by multiBamCov. 
Positive and negative motif hits inside peaks containing discSNPs impacting a GATA1 
motif were not used. MEME was then used to scan for contextual DNA motif regulators of 
GATA1 binding (considered all motifs that regulate GATA1 binding with p < 0.05, n=25) 
within 100 bp of the GATA1 motif hit for both the positive and negative sets. 
We first identified the contextual motifs that improved GATA1 binding site 
prediction in a logistic regression model that considers just the GATA1 MEME score vs 
one that also considers the MEME score of a nearby contextual motif PWM. As a control, 
we evaluated the change in ROC AUC relative to addition of a random column-wise shuffle 
of the contextual motif PWM. We tested each motif against 100 random shuffles in 10 
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separate runs where the GATA1 positive binding set was compared to different random 
draws of GATA1 negative binding sets. Those motifs that outperformed their shuffles > 
90% of the time were then included in a logistic regression classifier that considered the 
MEME scores of the GATA1 motif and of each contextual motif. This regression model was 
evaluated relative to a model only containing the GATA1 motif MEME score and a separate 
model that includes random shuffles of the contextual motifs. All regression models were 
performed with 10x cross-validation to avoid overfitting. 
Sensitivity of peak calling was compared between the GATA1 PWM only model and 
the model incorporating nearby contextual motifs by examining the true positive rate at 
an FDR of 0.3 (GATA PWM only model did not perform well enough to yield any threshold 
with an FDR of 0.1, so we relaxed the FDR to make a valid comparison). 
Data Availability 
The data sets generated during and/or analyzed during the current study are 
available from the corresponding author upon reasonable request. 
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In this chapter, we examine the role for the BRD4 transcription factor and for 
histone marks in bookmarking the erythroid transcriptional state across mitosis. To start, 
we used genome wide ChIP-seq to evaluate whether BRD4 might occupy mitotic 
chromatin on a genome-wide scale. We found that BRD4 does widely bind chromatin 
during mitosis, and that mitotic binding is enriched at erythroid-specific genes and at 
genes with rapid transcriptional reactivation following mitosis. The recent development 
of JQ1 as a rapid competitive inhibitor of BRD4 allowed for clean functional studies of 
BRD4’s role as a mitotic bookmark by reversibly perturbing binding during mitosis 
without impacting BRD4 protein levels during early G1.  Surprisingly, in spite of the 
widespread assumption that BRD4 functions as a mitotic bookmark, we find that mitotic 
BRD4 binding is dispensable for transcriptional reactivation. However, by combining 
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chromatin mass spectrometry with ChIP-seq, we identified multiple histone acetylation 
marks retained on mitotic chromatin that function as the primary substrate for BRD4 
mitotic chromatin occupancy and may operate as transcriptional bookmarks during 
mitosis. Moreover, this work highlights that the mere association of a given factor with 
mitotic chromatin does not necessarily imply a functional role in bookmarking 
transcription. 
3.1 BRD4 is partially retained on chromatin during mitosis 
For these studies, we again used G1E-ER4 cells as a model system for studying 
transcription factor biology in the context of mitotic bookmarking. Notably, BRD4 is 
required in G1E-ER4 cells for proliferation and GATA1-mediated gene activation upon 
differentiation (Stonestrom et al., 2015). To examine changes in BRD4 chromatin 
occupancy during mitosis on a genome-wide scale, we performed BRD4 ChIP-seq on G1E-
ER4 cells that were first induced to differentiate, and then either grown asynchronously 
(98% interphase) or arrested in mitosis and sorted to > 95% purity (Campbell et al., 2014). 
Since a previous study noted that nocodazole treatment of murine EB3 ES cells impaired 
normal localization of BRD4 to mitotic chromatin (Nishiyama et al., 2006), we arrested 
cells in mitosis by either nocodazole treatment (3 replicates) or by ro3306-induced arrest 
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(Vassilev et al., 2006) at the G2/M checkpoint followed by a 30-minute release into 
mitosis (2 replicates).  Peak calling using standard parameters identified 4,787 BRD4 
binding sites during interphase and 1,046 BRD4 binding sites during mitosis, of which 
490 sites were called during both interphase and mitosis. Comparison of BRD4 binding 
intensities (normalized to library size and “input” chromatin) at these peaks using either 
principal component analysis (PCA) or Spearman correlation shows clear separation 
between interphase and mitosis replicates regardless of whether mitotic arrest was 
achieved using nocodazole or ro3306 (Appendix Fig. A.17). 
Initial quantitative analysis of these binding data suggests that BRD4 occupies 
mitotic chromatin with a median of 20% of interphase binding intensity (Fig. 7a). 
However, library-size-normalization has been shown to be quantitatively inaccurate in 
situations where global protein levels might not be identical (Guertin et al., 2018; Orlando 
et al., 2014). Therefore, we tested absolute binding of BRD4 to interphase and mitotic 
chromatin by ChIP-qPCR, which has the advantage that signal is normalized to input 
chromatin. We extracted virtual ChIP-qPCR intensities at a panel of 17 loci suggested by 
ChIP-sequencing to have mitotic BRD4 occupancies ranging from < 1% to 130% of 
interphase binding (Fig. 7b). Strikingly, we find that library-normalized ChIP-seq 
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drastically underrepresents the absolute amount of BRD4 bound at all tested loci during 
mitosis (Fig. 7b, Appendix Fig. A.18).  
In order to overcome the global bias that results from quantification of library-
scaled ChIP-seq data, we devised a procedure to use the panel of BRD4 ChIP-qPCR data 
to retroactively normalize BRD4 ChIP-seq data in a replicate- and cell-cycle-stage- specific 
manner (Fig. 7c, details in Methods). We benchmarked the accuracy and consistency of 
this method by randomly selecting between 2 and 10 actual ChIP-qPCR data to scale the 
ChIP-seq data, and then assessing the concordance between ChIP-seq data and ChIP-
qPCR measurements of 5 qPCR loci outside of that original set (details in Methods). We 
find that the mean absolute percent deviation (MAPD) using library-size-normalization 
alone ranges between 123-145%, while qPCR-based scaling predicts out-of-sample qPCR 
data significantly better with MAPD between 62-68% trained on at least 6 loci (Fig. 7d). 
Similarly, the Pearson correlation coefficient between the ChIP-seq estimates and actual  
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Figure 7 - Genome-wide retention of BRD4 on mitotic chromatin. 
(a) Mitotic retention of BRD4 binding at 5343 interphase/mitotic peaks, scaled by library normalization. Peaks 
with no detectable mitotic binding are set to y = -12, peaks with no detectable interphase signal are set to y = 
8. (b) Relative mitotic retention of BRD4 binding at 17 interphase BRD4 peaks, measured by either ChIP-
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qPCR or by ChIP-seq (virtual qPCR). Dotted line represents equal interphase and mitotic binding, all peaks 
are normalized to interphase binding intensity. (c) Schematic describing qPCR-based scaling of ChIP-seq 
libraries. (d) Mean absolute percent deviation and (e) Pearson correlation coefficient comparing measured 
ChIP-qPCR intensities with predicted ChIP-qPCR data at out-of-sample BRD4 peaks. Predictions were made 
using either library-normalized ChIP-seq data (red bars) or qPCR-scaled ChIP-seq data (blue bars). (f) Mitotic 
retention of BRD4 binding at 5343 interphase/mitotic peaks, scaled by ChIP-qPCR data. Peaks with no 
detectable mitotic binding are set to y = -12, peaks with no detectable interphase signal are set to y = 10. (g) 
Percentage of BRD4 peaks, categorized by direction of peak change during mitosis, that are TSS-proximal (-1 
kb to + 100 bp), intronic, intergenic, or elsewhere. Significance determined by BH-corrected chi-square testing 
of the loss/gain groups relative to the unchanging peak group, * q < 0.05.  
ChIP-qPCR values for out-of-sample loci falls between 0.35-0.37 for library-size-
normalization and between 0.60-0.63 when using qPCR-based scaling trained on at least 
6 loci (Fig. 7e). These data thus support the use of qPCR-based scaling in addition to 
library-size-normalization to provide accurate and consistent quantitation of ChIP-seq 
data using as few as 6 qPCR loci. 
By applying qPCR-based scaling to all BRD4 ChIP-seq data, we find that BRD4 in 
fact occupies mitotic chromatin with a median of 54% of interphase binding intensity (Fig 
7f). Using a Wilcoxon test to examine significant (p < 0.05) changes in binding intensity, 
we find that 1,593 BRD4 peaks significantly lose BRD4 binding during mitosis, 297 peaks 
significantly gain binding, and 3,453 peaks show no evidence of altered binding in mitosis 
(Appendix Fig. A.19). Notably, BRD4 peaks that gain binding during mitosis are 
significantly more likely to be intergenic and less likely to be intronic or promoter-
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proximal, while peaks that lose binding during mitosis are enriched for TSS regions (Fig. 
7g). Together, these data reflect significant retention of BRD4 interphase binding on 
mitotic chromatin that would be drastically underestimated by simple peak calling or by 
library-normalized quantification of peak intensities. 
3.2 During mitosis, BRD4 peaks change in both intensity and shape 
Since BRD4 has been shown to bind both acetylated transcription factors (TFs) 
and acetylated histones (Shi and Vakoc, 2014), we reasoned that it would bind chromatin 
with a variety of peak profiles. BRD4 recruitment by acetylated TFs in nucleosome-
depleted regions (NDRs) often leads to focal peaks positioned between the peaks of 
acetylated flanking nucleosomes (Stonestrom et al., 2015) (Fig. 8a), while recruitment by 
acetylated histones leads to BRD4 peaks with broad but varied shapes (Fig. 8b and Fig. 
8c). To comprehensively characterize BRD4 binding intensity and shape, we applied 
principal component analysis (PCA) to ChIP-seq intensities (input-subtracted, qPCR-
scaled) extracted in 10-bp bins across the 5,343 BRD4 peaks (Fig. 8d). We find that 75% 
of the variation in BRD4 chromatin occupancy can be explained by three PCs that describe 
distinct aspects of peak intensity (PC1) or peak shape (skew: PC2, focality: PC3) (Fig. 8d). 
By deconvoluting these peak characteristics, we are able to confirm that during interphase, 
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BRD4 binds to GATA1-only peaks in a focal manner (high PC3 values) and binds to either 
H3K27ac-only or H3K27ac/GATA1 co-bound peaks in an anti-focal manner (low PC3 
values) (Fig. 8e). During interphase, we also find that BRD4 does not bind H3K27ac in a 
uniform manner, but rather exhibits markedly more focal binding at promoter regions 
than at either intronic or intergenic regions (Fig. 8f). Together, we find that a PCA-based 
approach of BRD4 chromatin occupancy provides a framework for examining 
heterogeneity in both peak intensity and structure. 
We next applied this peak analysis approach to BRD4 mitotic occupancy data to 
comprehensively examine changes in occupancy between interphase and mitosis. 
Separate PCA of interphase and mitotic BRD4 data results in PCs have almost identical 
eigenvectors (Appendix Fig. A.20a) and distributions of peak projections onto these PCs 
(Appendix Fig. A.20b), suggesting that BRD4 peaks have similar defining characteristics 
in both phases of the cell cycle. By applying k-means clustering to the changes in PC1/2/3 
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Figure 8 - Changes in BRD4 peak intensity and shape during mitosis 
(a-c) BRD4 peak calls and interphase ChIP-seq tracks for BRD4, GATA1, and H3K27ac in G1E-ER4 cells at the 
Spna2, Sp1, and Ctage5 genes. Tracks for a given factor are scaled identically. (d) PCA on BRD4 binding 
intensity across 5343 interphase/mitotic peaks collected in 10-bp bins yields 3 PCs (total 75% of variance 
explained) whose eigenvectors (contributions of bin locations to each PC) are displayed in the top row. Dotted 
line shows the mean coefficient value across all bins for that PC. Bottom row shows BRD4 peak profiles (mean 
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+/- 95% CI) for peaks within either the top or bottom 10% of peak projection value onto each of the top 3 PCs. 
Heatmap shows all peak intensities (peak center +/- 500 bp) during interphase, shown in descending order of 
mean intensity in the central 200 bp. (e) BRD4 peak projections onto PC3 (focality) categorized by co-
occupancy by GATA1 and/or H3K27ac.  (f) H3K27ac-bound BRD4 peaks, categorized by peak location. For (e) 
and (f), boxplot center is median PC3 value, hinges are 25% and 75% percentiles, statistics are Wilcoxon test, 
* p < 0.001. (g) K-means clustering of all BRD4 peaks based on changes in peak PC1/2/3 features between 
interphase and mitosis. Profiles show cluster intensity mean +/- 95% CI. Mean intensity and delta peak 
projections are shown as mean +/- SEM. (h) Brd4 intensity (mean +/- SEM) at Type 1 and Type 2 peaks (green) 
during either interphase or mitosis. Brd4 intensity (mean +/- SEM) for matched control regions located either 
10 kb 5’ (red) or 10 kb 3’ (blue) to the peak center are shown. 
projection value that BRD4 peaks undergo between interphase and mitosis, we find that 
the mitotic dynamics of BRD4 peaks fall into two major categories. Type 1 BRD4 peaks 
(84%) exhibit primarily altered BRD4 peak structure comprised of a shift in peak center 
either in the 3’ (Type 1a) or 5’ (Type 1b) direction, or a shift towards a more anti-focal 
shape (Type 1c) (Fig. 8g). Notably, despite 92% of these peaks being called only during 
interphase (Appendix Fig. A.21), we find that during mitosis these regions retain an 
average of 69% of their interphase intensity and have significantly more binding than 
neighboring control regions (identical peak size, 10kb upstream or downstream) (Fig. 8h), 
suggesting that peak calling of these regions during mitosis is heavily impacted by the 
change in peak shape. Type 2 BRD4 peaks (16%) exhibit a large increase in BRD4 intensity 
during mitosis (Fig. 8g). Although the majority (62%) of Type 2 peaks are not called during 
interphase, we find that 57% of these “mitosis-only” peaks have increased interphase 
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binding relative to both neighboring control regions, suggesting instead that most Type 2 
BRD4 peaks are bound during both interphase and mitosis (Fig. 8h). Thus, we find that 
PCA-based analysis of changes in BRD4 binding during mitosis reveals 2 major classes of 
BRD4 peak dynamics that would be otherwise obscured by traditional peak-calling 
approaches. 
3.3 BRD4 chromatin occupancy displays features of mitotic bookmarking  
Given the finding that BRD4 remains broadly bound to chromatin during mitosis, 
we next asked whether BRD4 exhibits defining features of a mitotic bookmark. Previous 
studies have suggested that a key function of mitotic bookmarking is to promote rapid 
reactivation of a transcriptional program in daughter cells in a manner that faithfully 
reflects that of the mother cell (Blobel et al., 2009; Dey et al., 2009; Kadauke et al., 2012; 
Zhao et al., 2011). We began by asking whether BRD4 binding to mitotic chromatin favors 
erythroid-specific genes.  To this end, we compared our classification of BRD4 peaks as 
Type 1 or Type 2 with expression changes of associated genes during erythroid 
differentiation. To identify differentiation-related expression changes, we compared RNA-
seq data either during primary cell differentiation from the megakaryocyte-erythroid 
precursor (MEP) to proerythroblast stage (Di Tullio et al., 2011) (Fig. 9a) or during 
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GATA1-induced differentiation of the G1E-ER4 proerythroblast cell line (Jain et al., 2015) 
(Fig. 9b). Both measures of erythroid differentiation show that Type 2-associated genes 
are more activated than either Type 1 or non-BRD4-bound genes. Together, these data 
suggest that Type 2 BRD4 peaks are preferentially found at erythroid-specific genes, 
consistent with a role for mitotic BRD4 occupancy in bookmarking of lineage-specific 
transcriptional programs. 
In order to test whether BRD4 mitotic occupancy is associated with more rapid 
transcriptional reactivation following mitosis, we examined the binding of RNA 
Polymerase II during and following mitosis (Hsiung et al., 2016) at different classes of 
BRD4-bound genes. Surprisingly, although Pol II is evicted from the majority of gene TSS 
regions during mitosis (Hsiung et al., 2016), we find that Type 2 genes retain significant 
Pol II TSS occupancy during mitosis (Fig. 9c). Notably, Type 2 genes have significantly  
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Figure 9 - BRD4 mitotic chromatin occupancy reflects multiple features of a bookmarking 
protein. 
 79 
RNA-seq gene expression changes during either (a) primary cell differentiation from MEP to proerythroblast 
or (b) GATA1-mediated differentiation of the G1E-ER4 proerythroblast cell line. Genes are categorized by 
having TSS-proximal Type 1 or Type 2 BRD4 binding or as having no TSS-bound BRD4. Boxplot center is 
median, hinges are 25% and 75% percentile, * Wilcoxon p< 0.05. (c) Interphase and mitotic RNA Pol II rpkm 
intensities for TSS/Gene body/TTS regions of genes associated with Type 1 BRD4 peaks or Type 2 BRD4 peaks, 
or of genes with no promoter-proximal BRD4 binding. TSS/TTS regions are 2.5 kb long centered on gene 
TSS/TTS, gene body is the space between these regions. Bars represent mean +/- SEM. (d,e) ChIP-seq tracks 
at the Nfe2l1 (d) and Cdk12 (e) genes for BRD4 and Pol II during interphase, arrested during mitosis, or 
released at 1.5h post-mitotic arrest. (f) Mitotic pausing index, normalized to interphase pausing index, genes 
categorized by type of TSS-proximal BRD4 binding. Left shows pausing index calculated by TSS rpkm divided 
by gene body rpkm, right shows pausing index calculated by TSS rpkm divided by TTS rpkm. Boxplot center 
is median pausing index, hinges are 25% and 75% percentiles. (g) Pol II recruitment kinetics following mitosis 
at Type 1 vs Type 2 genes (based on BRD4 TSS binding) in either the TSS, gene body, or TTS regions. Plotted 
are the fraction of genes at a given time point that have returned to baseline (defined by asynchronous time 
point) Pol II levels in that region of the gene. Significance was by Chi Square test, * q < 0.001. 
higher rates of TSS-proximal pausing during mitosis (Fig. 9d-f), suggesting that these 
genes may be primed for transcription but not actively engaged in transcription during 
mitosis. As additional validation of these results, we find that Pol II ChIP-qPCR during 
interphase and mitosis confirms increased TSS-proximal Pol II retention at Type 2 genes 
Cdk12, Nfe2l1, and Atp5b, as well as increased promoter-proximal pausing during mitosis 
at Atp5b (Appendix Fig. A.22). Additionally, we find that, despite subsampling to match 
asynchronous Pol II intensities across gene sets, Type 2 genes recover Pol II density 
following mitosis at their TSS, gene body, and TTS regions significantly faster than Type 1 
genes, thus connecting BRD4 mitotic dynamics to transcriptional reactivation kinetics 
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following mitosis (Fig. 9g). In total, we find BRD4 mitotic binding to be associated with 
multiple features of mitotic bookmarking in erythroid cells. 
3.4 Transient competitive inhibition during mitosis suggests that BRD4 is 
not required for mitotic bookmarking 
While BRD4 occupies chromatin during mitosis in a pattern suggestive of mitotic 
bookmarking, it was unclear whether BRD4 plays an active role as a mitotic bookmark. An 
alternative possibility is that BRD4 passively remains bound to mitotic chromatin, 
especially at genes that are bookmarked by alternative mechanisms, without playing a 
functional bookmarking role itself. Previous studies testing this question used either 
siRNA (Zhao et al., 2011)/shRNA (Dey et al., 2009) -based knockdown or treatment with 
the BET protein competitive inhibitor JQ1 (Zhao et al., 2011), applied across the entire cell 
cycle. However, these approaches cannot definitively test whether BRD4 chromatin 
occupancy specifically during mitosis is required for post-mitosis gene activation since, in 
multiple contexts (Shi and Vakoc, 2014; Wang and Filippakopoulos, 2015), BRD4 is 
required for widespread gene activation during interphase. Since JQ1 has been shown to 
inhibit BRD4 rapidly (Delmore et al., 2011) and reversibly (Brown et al., 2018; Kurimchak 
et al., 2016), we hypothesized that transient JQ1 treatment during mitosis would remove 
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BRD4 from mitotic chromatin without perturbing the availability of BRD4 for 
transcription following mitosis. To this end, we treated cells arrested in mitosis with a 1-
hour pulse of 250 nM BET protein competitive inhibitor JQ1 followed by immediate cell 
fixation and BRD4 ChIP-seq. We identified just 96 BRD4 peaks following transient mitotic 
JQ1 treatment, of which only 28 overlapped with our consensus interphase/mitosis set of 
5,343 BRD4 peaks. Further, following transient JQ1 treatment, both Type 1 and Type 2 
BRD4 peaks undergo a dramatic loss in BRD4 occupancy (Fig. 10a). Thus, we find that 
BRD4 is almost completely removed from mitotic chromatin on a genome-wide scale 
following as little as 1 hour of 250 nM JQ1 treatment. 
To directly test the requirement of mitotic BRD4 in promoting rapid 
transcriptional reactivation, we transiently inhibited BRD4 chromatin occupancy in 
nocodazole-arrested mitotic cells using either 1 uM (Appendix Fig. A. 23) or 10 uM (Fig. 
10c) JQ1 compared to a DMSO control. Next, we washed out both nocodazole and JQ1, 
released cells in G1 for varying lengths of time, and measured nascent transcript 
production for 16 genes by primary transcript RT-qPCR. All cells were induced to 
differentiate for a total of 13 hours so that differentiation status would not confound 
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Figure 10 - BRD4 does not operate as a mitotic bookmark in erythroid cells.  
(a) Mean binding intensity at BRD4 peaks, categorized by Type 1 vs Type 2, during interphase, mitosis, or 
during mitosis treated with 1 hr 250 nM JQ1, mean +/- 95% CI. (b) Schematic describing how mitotic 
bookmarking function can be tested by using rapid competitive inhibition that removes BRD4 from chromatin 
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only during mitosis. (c) Comparison of RT-qPCR quantities for 16 primary transcripts after treatment with 
either 10 uM JQ1 or DMSO during mitosis. Dotted black line represents equal levels; dotted red lines show 2-
fold difference. Data are normalized to GAPDH mature transcript and to mean quantity across all time points. 
(d) Pol II ChIP-qPCR following either 1-hour 250 nM JQ1 or DMSO treatment shows minimal changes in 
binding. All values are mean +/- SEM, n = 3. (e) Pol II TSS rpkm at 385 Cluster 4-associated genes in mitotic 
cells treated either with 250 nM JQ1 or a DMSO control. Left, mean +/- sem across all genes. Right, scatterplot 
of log2(rpkm), line represents equal binding, contours represent 2D kernel density estimation. 
transcriptional output (Fig. 10b, cartoon of experiment). Surprisingly, we found no 
significant changes in nascent transcription at 1, 2, 4, or 6 hours following mitosis for any 
of the 16 tested genes (Fig. 10c). These data suggest that while BRD4 chromatin occupancy 
during mitosis displays multiple features of mitotic bookmarking, BRD4 is not required 
for mitotic bookmarking in erythroid cells. Moreover, since JQ1 also targets BRD2 and 
BRD3 with comparable efficiency (Dawson et al., 2011; Filippakopoulos et al., 2010; 
Nicodeme et al., 2010) and since both BRD2 and BRD3 are found on mitotic chromatin 
(Kanno et al., 2004; Shao et al., 2016), we surmise that none of the BET proteins function 
as mitotic bookmarks of transcription in these cells. 
Given the high correlation of Pol II TSS mitotic retention with Type 2 BRD4 peaks, 
we hypothesized that removal of BRD4 from mitotic chromatin would impact the presence 
of Pol II in these TSS regions. Surprisingly, treatment during mitosis with 1 hour of 250 
nM JQ1 does not alter Pol II mitotic occupancy by either ChIP-qPCR (Fig. 10d) or ChIP-
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seq (Fig. 10e) at Type 2 -associated genes. These data suggest that BRD4 does not directly 
recruit Pol II to the TSS regions of Type 2 genes during mitosis. Together, we find that Pol 
II TSS occupancy during mitosis does not require BRD4 chromatin occupancy and may 
serve as an independent measure related to mitotic bookmarking.  
3.5 Histone acetylation is broadly retained on mitotic chromatin 
BRD4 has been shown to bind multiple histone acetylation marks in vitro and in 
vivo, and its retention on mitotic chromatin may also involve histone acetylation (Dey et 
al., 2009; Kruhlak et al., 2001; Zhao et al., 2011). In order to obtain an unbiased 
characterization of changes in the histone PTM landscape across the cell cycle, 
quantitative HPLC-MS/MS was performed on purified histones from either asynchronous 
or mitotic undifferentiated G1E-ER4 cells. Mass spectrometry (MS) has an advantage over 
antibody-based methods in that histone mark antibodies can have variable specificity and 
that binding to their epitopes can be influenced by contextual histone modifications. 
Moreover, MS enables quantification of combinatorial modifications occurring on the 
same peptide. By quantifying changes in abundance (as a fraction of total peptide counts) 
of 60 distinct histone PTM combinations, we find that, except for the mitosis-specific 
histone phospho-PTMs H3S10ph and H3S28ph (Wang and Higgins, 2013), most histone 
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PTMs undergo minimal changes in global abundance between interphase and mitosis (Fig. 
11a and Fig. 11b). Notably, multiple histone acetylation PTMs that co-localize or directly 
interact with BRD4 (Dey et al., 2003; Filippakopoulos et al., 2012; Stonestrom et al., 2015) 
exhibit mitotic global abundance ranging from 23% (H3K27ac) to 154% (H3K122ac) of 
interphase abundance (Fig. 11b and Fig. 11c). Quantitative western blot of whole cell 
lysates from asynchronous and mitotic G1E-ER4 cells differentiated for 13 hours confirms 
broad global retention of these histone acetyl PTMs during mitosis (Fig. 11d). Additionally, 
we find that di-acetyl H3 and H4 PTM combinations, which have been shown to be 
preferred substrates over mono-acetylated histones (Dey et al., 2003), are either constant 
or increased in relative abundance during mitosis (Fig. 11e).  
It is possible that binding of BRD4 and/or other BET proteins to mitotic chromatin 
might promote mitotic histone acetylation, either by directly functioning as a histone 
acetyltransferase (Devaiah et al., 2016a) or by protecting acetyl marks from deacetylases.  
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Figure 11 - Histone methylation and acetylation are broadly preserved on mitotic chromatin.  
(a) Changes in abundance of histone PTM categories between interphase and mitosis. (b) Changes in 
individual histone PTM abundance between interphase and mitosis. (c) Changes in abundance of particular 
BRD4-binding histone PTMs between interphase and mitosis. (d) Quantitative western blots of BRD4, 
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GAPDH, and multiple histone PTMs during interphase, mitosis, or during mitosis following 1-hour 250 nM 
JQ1 treatment. Non-JQ1 conditions were treated with 1-hour 250 nM DMSO. Quantitation involves 
normalization to within-lane background, GAPDH, and the interphase condition. Conditions with error bars 
represent n = 2 experiment, mean +/- SEM, other conditions are n = 1. (e) Changes in the abundance of 
particular histone di-PTM combinations between interphase and mitosis. For (a)-(c) and (e), PTM abundance 
is normalized to peptide abundance. 
To determine whether the removal of BET proteins from mitotic chromatin de-stabilizes 
these marks, we carried out Western blots for relevant acetyl marks using extracts from 
mitotic cells exposed to 250 nM JQ1. Notably, treatment had no impact on the abundance 
of these marks, suggesting that BET proteins are not required for their maintenance or to 
shield them from removal (Fig. 11d, see also below). In summary, we find broad retention 
of histone acetylation and methylation PTMs on mitotic chromatin.  
3.6 Histone acetylation marks undergo dynamics during mitosis that reflect 
multiple features of bookmarking 
While mass spectrometry and Western blots show that histone acetylation is 
globally retained on mitotic chromatin, these methods cannot assess potential changes in 
the genomic distributions of histone modifications during mitosis. To this end, we 
performed ChIP-seq on either interphase or mitotic differentiating G1E-ER4 cells for total 
H3, the mitosis-specific PTM H3S10ph, 4 histone acetylation PTMs (H3K14ac, H3K27ac, 
H3K122ac, H4K16ac) and for the histone variant H2AZ, which has been previously 
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described to undergo changes in occupancy during mitosis (Kelly et al., 2010). These four 
acetyl PTMs and H2AZ have been shown to be associated with active transcription (Calo 
and Wysocka, 2013; Pradeepa et al., 2016) and to be substrates for BET protein chromatin 
occupancy (Devaiah et al., 2016a; Dey et al., 2003). We applied ChIP-qPCR-based scaling, 
described above, to identify absolute changes in mark abundance at each mark’s respective 
peaks (Fig. 12a, Appendix Fig. A.24). Strikingly, global changes in the abundance of these 
histone acetyl PTMs are highly concordant when measured by MS vs ChIP-seq only when 
the ChIP-seq data are qPCR-scaled (unscaled Pearson: -0.76, qPCR-scaled Pearson: 0.75). 
We applied a threshold of 2-fold change in peak rpkm to define peaks as either 
unchanged, increased in mitosis, or decreased in mitosis (Fig. 12b). In total, we find 
minimal changes in total H3 density and that H3S10ph is highly skewed towards increased 
signal during mitosis, as expected.  Additionally, among peaks that change during mitosis, 
we find that H2AZ, H3K122ac, and H4K16ac peaks are mostly increased during mitosis, 
while H3K14ac and H3K27ac primarily exhibit a reduction of intensity during mitosis. The 
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Figure 12 - Multiple histone marks are retained on mitotic chromatin with features 
characteristic of mitotic bookmarking.  
(a) Mitotic retention of histone PTM signal at the interphase/mitotic peaks called for each PTM, scaled by 
ChIP-qPCR data. (b) Fraction of peaks for each PTM that were identified as unchanged during mitosis (< 2-
fold signal change compared to interphase), gained during mitosis (> 2-fold increase), or lost during mitosis 
(> 2-fold decrease). (c) RNA-seq gene expression changes during GATA1-mediated G1E-ER4 differentiation 
for genes that had unchanged TSS-proximal occupancy of a given PTM vs genes that gained TSS-proximal 
occupancy for that mark. Boxplot center is median pausing index, hinges are 25% and 75% percentiles, 
significance assessed by Wilcoxon test, * p < 0.05. (d) Pol II recruitment kinetics following mitosis at genes 
with either loss, gain, or unchanged TSS-proximal occupancy of a histone PTM during mitosis (cutoff was 2-
fold change). Pol II density was assessed within the TSS region. Plotted are the fraction of genes at a given 
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time point that have returned to baseline (defined by asynchronous time point) Pol II levels in that region of 
the gene. Significance was by Chi Square test, * q < 0.05. 
maintenance or increase in histone mark intensity during mitosis may serve multiple 
functions, including as a bookmark of erythroid lineage-specific genes.  
We thus sought to identify whether dynamics in histone PTM intensity during 
mitosis might indicate a role in mitotic bookmarking of the erythroid lineage. First, we 
asked whether histone PTM occupancy during mitosis is particularly enriched at 
erythroid-specific genes. To this end, at genes with a TSS-proximal peak for H2AZ or a 
histone acetylation PTM, we compared changes in histone mark intensity during mitosis 
with changes in gene expression during G1E-ER4 proerythroblast differentiation (Jain et 
al., 2015). Indeed, we find that genes with increased H2AZ or H3K122ac signal intensity 
during mitosis are significantly more erythroid-specific than genes with unchanged 
occupancy of these PTMs (Fig. 12c), with H4K16ac trending in the same direction but 
having a smaller sample size for significance testing.  
We next asked whether histone marks on mitotic chromatin correlate with faster 
transcriptional reactivation following mitosis. As a proxy for transcription reactivation 
kinetics, we examined the re-recruitment of RNA Polymerase II to TSS and gene body 
regions following near complete eviction of Pol II from chromatin during mitosis (Hsiung 
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et al., 2016). Since H2AZ, H3K14ac, H3K27ac, H3K122ac, and H4K16ac each associate 
with active gene transcription, we grouped together for this analysis all genes that have an 
increase in TSS-proximal intensity of any of these marks during mitosis and grouped 
separately all genes with a decrease in any of these marks during mitosis. Strikingly, 
despite using subsampling to match asynchronous Pol II intensities across groups, we find 
that genes with increased intensity of any of these marks during mitosis are re-activated 
following mitosis with significantly faster kinetics than genes with decreased PTM 
intensity (Fig. 12d). In total, these data suggest that histone marks undergo significant 
dynamics during mitosis, and that these dynamics are consistent with multiple defining 
features of a mitotic bookmark.   
3.7 Histone acetylation is the primary substrate for BRD4 mitotic chromatin 
occupancy 
Since multiple histone acetylation PTMs that are bound by BRD4 during 
interphase remain present on mitotic chromatin, we hypothesized that these acetyl PTMs 
might also function as substrates for BRD4 binding to chromatin during mitosis. Given 
the lack of available tools for perturbing histone PTMs specifically during mitosis, we 
turned to a predictive modeling approach to identify substrates of BRD4 chromatin 
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occupancy at a set of 5,343 BRD4 peaks (Fig. 8b). At these peaks, we first extracted 
interphase or mitotic 10-bp binned intensities for GATA1, total H3, H2AZ, and multiple 
histone acetyl PTMs (Fig. 13a). For each potential BRD4 binding partner, we used these 
extracted intensities to construct a sparse generalized linear model with 10X cross-
validation and evaluated model performance based on its ability to predict BRD4 peak 
intensity (PC1) or shape (PC2/PC3) characteristics during either interphase or mitosis. In 
total, we expect this modeling approach to incorporate any aspect of GATA1 binding or 
histone PTM occupancy that might predict BRD4 binding, and furthermore, to quantify 
the relative contributions of these potential substrates to the BRD4 chromatin landscape. 
Previous studies have shown that during interphase, BRD4 binds both acetylated 
GATA1 and acetylated histones (Shi and Vakoc, 2014).  To benchmark this predictive 
modeling approach, we first tested whether interphase intensity of either GATA1 or 
histone acetylation PTMs might independently predict BRD4 interphase chromatin  
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Figure 13 - Histone acetylation predicts BRD4 occupancy on mitotic chromatin.  
(a) Description of a pipeline for testing the ability of various chromatin features to predict BRD4 chromatin 
occupancy. (b) Pearson correlation coefficient between prediction of BRD4 peak PC1 (intensity) projections 
and actual BRD4 peak PC1 projections during interphase. Prediction inputs (interphase data only) are shown 
on the x-axis, bars represent mean +/- SEM. (c) Pearson correlation coefficient between prediction of BRD4 
peak shape features (PC2, PC3 projections) and actual BRD4 peak shape features during interphase. 
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Prediction inputs (interphase data only) are either GATA1 or H3K27ac, bars represent mean +/- SEM, * p < 
1e-4. Left panel uses all BRD4 peaks, right panel uses only peaks co-bound by all of BRD4/GATA1/H3K27ac. 
(d) Pearson correlation coefficient between prediction of BRD4 peak PC1 (intensity) projections and actual 
BRD4 peak PC1 projections during mitosis. Prediction inputs (mitosis data only) are shown on the x-axis, bars 
represent mean +/- SEM. Left panel uses all BRD4 peaks, right panel uses only Type 2 BRD4 peaks. (e) 
Receiver operating characteristic curves for classification of BRD4 peaks as Type 1 vs Type 2. Prediction inputs 
are colored in legend, curves are mean of independent runs. 
occupancy. Indeed, we find that GATA1 and the four tested histone acetylation PTMs 
(H3K14ac, H3K27ac, H3K122ac, H4K16ac) are each individually predictive of BRD4 
binding intensity (PC1) (Fig. 13b). Notably, the combination of all four histone PTMs 
(H3K14ac, H3K27ac, H3K122ac, H4K16ac) outperforms any of these marks individually, 
suggesting that BRD4 interacts with these marks in a non-redundant fashion. Strikingly, 
we find that interphase BRD4 peak shape features are much better predicted by GATA1 
binding than by H3K27ac (Fig. 13c). This finding persists even when considering the 2,243 
BRD4 peaks that are bound by both GATA1 and H3K27ac (Fig. 13c), suggesting that 
GATA1 is more likely than histone acetylation to tether BRD4 to interphase chromatin 
when both are available. This further illustrates how consideration of peak shape in 
addition to peak intensity allows for mechanistic inferences related to chromatin 
occupancy of histone reader molecules. 
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We next examined the role of GATA1 and histone acetylation during mitosis in 
predicting mitotic BRD4 occupancy. Unlike during interphase, we find that general 
markers of nucleosome positioning, such as total H3 and H3S10ph, have significant 
predictive power of BRD4 binding intensity during mitosis (Fig. 13d). Since Type 1 BRD4 
peaks become less focal and might represent a non-specific association of BRD4 with 
mitotic chromatin, we presumed that removal of these peaks from the prediction analysis 
would worsen the predictive power of general nucleosome position. When restricting our 
analysis to prediction of Type 2 BRD4 peaks, we do find that total H3 and H3S10ph have 
reduced, but not zero, predictive power of mitotic intensity (Fig. 13e), suggesting that 
nucleosome positioning is a significant determinant of both Type 1 and Type 2 BRD4 peaks 
during mitosis, unlike during interphase. Surprisingly, although GATA1 is partially 
retained on chromatin during mitosis (Kadauke et al., 2012), we find that during mitosis, 
GATA1 is not more predictive than H3S10ph of BRD4 binding (Fig. 13e). In contrast, 
mitotic BRD4 peak intensity is highly predicted by H3K14ac, H4K16ac and H3K122ac. 
Strikingly, H3K27ac, one of the strongest predictors of BRD4 binding during interphase, 
is not more predictive than total H3 during mitosis, consistent with our findings that 
H3K27ac binding is much less preserved during mitosis than other acetylation PTMs. 
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Similarly, we find that despite serving as key binding partners for BRD4 binding during 
interphase, H3K27ac and GATA1 are no better than total H3 at binary classification of 
BRD4 peaks as Type 1 vs Type 2, unlike H3K14ac, H4K16ac or H3K122ac (Fig. 13f). 
Together, these data suggest that during mitosis, there is a diminished, if not absent, role 
for GATA1 in the recruitment of BRD4 and that histone acetylation serves as the primary 
partner for BRD4 binding. Together, these findings underscore the value in considering 
peak distributions, intensities, and shapes to infer the mechanisms by which BRD4 
occupies chromatin.  
3.8 Methods 
Isolation of mitotic G1E-ER4 cells 
Culture of G1E-ER4 cells was performed as previously described (Weiss et al., 
1997). G1E-ER4 cells were induced by addition of 100 nM estradiol for 13 hours total. At 
5 hours post-induction, cells were arrested in pro-metaphase by addition of either ro3306 
(2 replicates of BRD4 ChIP-seq) or nocodazole (3 replicates of BRD4 ChIP-seq, 2 
replicates for all other targets). Nocodazole-treated populations were fixed with 1% room 
temperature formaldehyde for 10 minutes at 13 hours post-induction. Treatment with the 
CDK1 inhibitor ro3306 (Vassilev et al., 2006) arrested cells at the late G2/mitosis 
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checkpoint, and so at 13 hours post-induction, ro3306 was washed out and cells were 
grown in media for 30 minutes at 37 degrees before formaldehyde fixation so that mitotic 
cells could be collected. Following fixation, cells were permeabilized, stained with anti-
MPM2 antibody (Campbell et al., 2014), and FACS sorted for either live singlets 
(asynchronous) or additionally for MPM2+ cells (mitotic). 
Chromatin Immunoprecipitation (ChIP) qPCR and sequencing 
ChIP was performed as previously described (Letting et al., 2004). qPCR primers 
are listed in Appendix Fig. A.26. Antibodies are as follows: Brd4 (Bethyl A301-985A), 
H2AZ (Abcam Ab4174), total H3 (Abcam ab1791), H3S10ph (Abcam ab5176), H3K14ac 
(Millipore 07-353), H3K27ac (Active Motif 39685), H3K122ac (Abcam ab33309), 
H4K16ac (Millipore 07-370). ChIP-seq samples were prepared by end repair, 3’ 
adenylation, and adaptor ligation using Illumina’s ChIP-seq Sample Preparation Kit. 
SPRIselect (Beckman Coulter) beads were used obtain an average library target size of ~ 
300 bp, followed by real-time qPCR quantification using the KAPA Library Quant Kit for 
Illumina (KAPA Biosystems catalog no. KK4835). Single-end sequencing (1x75 bp) was 
performed on the Illumina NextSeq 500 in high-output mode using Illumina sequencing 
reagents according to Illumina instructions, and bclfastq2 v 2.15.04 (default parameters) 
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was used for conversion of reads to fastq. Fastq reads were aligned to the mm9 genome 
using bowtie 2 (parameters: --end-to-end --very-sensitive). 
RT-qPCR of primary transcripts 
We prepared RNA using TRIzolTM (ThermFisher Scientific, Cat # 15596018) and 
purified using the RNeasy Mini kit with on-column DNAse treatment (Qiagen, Cat # 
74106). Reverse transcriptase reactions were performed using iScript (Bio-Rad, Cat 
#1708841) and qPCR reactions were prepared with Power SYBR Green (ThermoFisher 
Scientific). All primary transcript primers flank intron exon-junctions, and primer sets are 
listed in Appendix Fig. A.26. Primary transcript quantities are normalized to Pabpc1 
mature mRNA, similar results were obtained when normalizing to Gapdh mature mRNA 
(data not shown). 
Extraction and purification of histones from intact whole cells 
We adapted previously described methods for isolation of histones for MS from 
purified nuclei (Sidoli et al., 2016) so that we could purify histones from mitotic cells that 
lack an intact nuclear envelope. We first prepared RIPA lysis buffer with the following 
inhibitors (final concentrations listed): protease inhibitors (1:250, Sigma, P8340), Sodium 
Fluoride (5 mM), Sodium Orthovanadate (1 mM), EDTA (5 mM), DTT (1 mM), and 
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Sodium Butyrate (10 mM). Cells were placed on ice, washed three times in cold PBS, and 
then rotated in the prepared RIPA buffer for 30 minutes at 4C. We then sonicated this 
material (Qsonica Q800R3) at 4C using 10 seconds on/10 seconds off for 2 minutes at 
100% amplitude, after which we proceeded with sulfuric acid extraction of histones and 
subsequent preparatory steps for HPLC-MS/MS as previously described (Sidoli et al., 
2016). 
Western blot 
Western blotting was performed using standard procedures. Antibodies are as 
follows: Brd4 (Bethyl A301-985A), H2AZ (Active Motif 39114), total H3 (Abcam ab1791), 
H3S10ph (Abcam ab5176), H3K14ac (Millipore 07-353), H3K18ac (Millipore 07-354), 
H3K27ac (Active Motif 39134), H3K122ac (Abcam ab33309), H4K16ac (Millipore 07-
370), GAPDH (Santa Cruz sc-365062). 
ChIP-seq peak calling 
Peaks were called for all ChIP-seq replicates separately using HOMER findPeaks 
(Heinz et al., 2010) (v4.9.1, parameters: -style histone) using cell-cycle-matched 
sequenced ChIP input. Peaks were required to be called in at least 2 replicates, and peak 
sets for each factor were merged between interphase and mitosis using BedTools merge 
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(Quinlan and Hall, 2010) (v2.22.0, default parameters). Peaks were excluded if they 
contained >50% overlap with blacklist or repeat regions. For the majority of analyses, peak 
intensities were extracted in 100 10-bp bins across a 1 kb-long peak centered on the 
variable-length peak that was initially called by using HOMER annotatePeaks (Heinz et 
al., 2010) (v4.9.1, parameters: -size 1000 –hist 10 –ghist –norm 1e7). Input ChIP-seq 
intensities were generated for the same regions in an identical manner and subtracted 
from each respective 10-bp bin. Finally, binned intensities were scaled by qPCR-derived 
scaling factors.  
Scaling of ChIP-seq datasets by ChIP-qPCR 
First, at each location tested by qPCR, the ChIP-seq intensities within that 70-90 
bp amplicon region were extracted by using HOMER annotatePeaks (Heinz et al., 2010) 
(v4.9.1, parameters: -size given –norm 1e7), which will normalize the library to 10e7 reads 
before determining the intensity. Given the diffuse nature of total H3 and H3S10ph signals 
genome-wide, we extracted intensities for these data in 1 kb regions centered on the qPCR 
amplicon. Input ChIP-seq intensities were generated for the same regions and subtracted 
to yield a “virtual qPCR” signal above input, and any signals less than or equal to zero were 
excluded from further analysis. We then divided the actual ChIP-qPCR quantity by the 
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virtual qPCR signal to determine the scaling factor for that particular qPCR amplicon and 
ChIP-seq data. The median of the scaling factors was calculated for each ChIP-seq data 
set, and this factor was then multiplied with any subsequently extracted peak or region 
intensity (input-subtracted and library-normalized) from that data set. 
For benchmarking of this method, we tested its accuracy and consistency by 
assessing its ability to predict out-of-sample BRD4 ChIP-qPCR intensities using scaled 
BRD4 ChIP-seq data, evaluated either by mean absolute percentage deviation (MAPD) or 
Pearson correlation. Here, we selected between 2-10 ChIP-qPCR data for generating a 
scaling factor and held back the other ChIP-qPCR loci for evaluation. Once a scaling factor 
was generated for a given ChIP-seq data set, 5 of the held back loci were randomly selected 
and their intensities were predicted using either library normalization alone or with the 




) and a Pearson correlation was done between the actual and 
predicted intensities. For each possible number of training qPCR data (between 2-10), we 
tested predictions across 1000 runs.  
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PCA-based approach to studying peak changes 
For a given ChIP factor and a set of 1-kb-long binding regions, we used principal 
component analysis (PCA) to deconvolute its binding characteristics within these regions. 
This consisted of first extracted ChIP-seq intensities (input-subtracted, qPCR-scaled) in 
10-bp bins across all of the regions, and then calculating the mean intensity value for each 
region/bin pair across all replicates for a given cell cycle phase or experimental condition. 
We then organized the intensities into a matrix such that each row represents a binding 
region and each of 100 columns represents the 10-bp bins that make up the 1 kb region. 
We scaled each column by subtracting the column mean from each value, and then 
dividing by the column standard deviation. We applied PCA to the scaled interphase data, 
and then multiplied the matrix corresponding to each condition for this factor by that 
interphase PCA rotation matrix to determine the projection of each binding region onto 
the interphase-derived eigenvectors. We used this approach since in all cases, the 
eigenvectors generated from separate conditions were nearly identical, and projection on 
to the same eigenvectors allows for more robust comparison of data from different 
conditions. 
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RNA Pol II mitotic occupancy analysis 
RNA Pol II ChIP-seq data were downloaded from GSE83293. Datasets were scaled 
by library size, and rpkm intensities were extracted from gene TSS, gene body, or TTS 
regions using UCSC bigWigAverageOverBed (v2, default parameters). TSS and TTS 
regions were defined as 2.5 kb windows centered on the annotated TSS and TTS, 
respectively. The gene body was defined as the window between these TSS/TTS regions, 
and only genes with a gene body window > 500 bp were analyzed. 
Predictive modeling of BRD4 chromatin occupancy 
To model likely binding partners for BRD4, we compared the ability of different 
chromatin-associated factors to predict BRD4 binding either during interphase or mitosis. 
To begin, we identified 1 kb BRD4 binding regions centered on the 5,343 set of joint 
interphase/mitotic BRD4 peaks (Fig. 8d). As input data, for each selected factor, we 
extracted qPCR-scaled intensities in 10-bp bins spanning the set of BRD4 binding regions. 
As output data, we used the BRD4 peak characteristics defined by PCA as in Fig. 8d, which 
together describe intensity (PC1), skew (PC2), or focality (PC3). We then used this set of 
input intensities for a given factor and output BRD4 binding characteristics to build a 
predictive model for BRD4 binding. To avoid model over-fitting, we split data into training 
and testing sets using 10x cross-validation. To achieve robust test predictions, we did 100 
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independent runs, each with scrambled peak ordering, such that each run consisted of 10 
cross-validation runs. We then applied PCA to the input data and used the PC projections 
as independent variables in an initial generalized linear model predicting a set of BRD4 
peak characteristics. From this model, we identified those PCs representing input data 
that significantly contribute to model with p < 0.05 in order to create a sparse model that 
avoids over-fitting to the training data. We then used only these sparse PCs to build a final 
model of the input data predicting the BRD4 peak characteristics. Finally, this model was 
applied to the testing data to evaluate the concordance between predicted BRD4 peak 
characteristics and actual values, assessed by Pearson correlation. 
Data availability 
The data sets generated during and/or analyzed during the current study are 





CHAPTER 4: Discussion 
Chapter Summary 
Transcription factors are a central part of transcriptional regulation and cellular 
identity in both normal contexts and in the setting of disease. They can coordinate 
widespread changes in gene activity by binding to and regulating many different genes in 
a given cell. In this work, we sought to understand how transcription factors can occupy 
so many distinct spatial and sequence contexts, often with an additional layer of temporal 
regulation of binding. In the first part of these studies (Chapter 2), we sought to clarify the 
DNA sequence determinants of TF binding to chromatin. To this end, we established a 
framework for using ChIP-seq data to both identify natural genetic variation between 
ENCODE cell lines and to reveal the impact of single nucleotide variation on TF binding 
to DNA. In the second part of these studies (Chapter 3), we sought to clarify whether the 
transcription factor BRD4 and/or histone acetylation marks remain constant on 
chromatin across the cell cycle. These studies tested an additional proposed function of 
transcription factors: bookmarking of cellular identity and transcriptional programs 
during the rigors of cell division. Precisely answering these aspects of TF biology has in 
many cases required the development of new methods and analytical approaches. In this 
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section, we will review biological insights provided by this work, advances in methodology 
that might be broadly applied to other contexts, and outstanding questions that might 
define future directions of study. 
DNA sequence variation identified from ChIP-seq data 
An essential prerequisite for our study is the careful identification of sequence 
variants in the genomes of ENCODE cell lines. Traditionally this has been accomplished 
by whole genome sequencing (WGS). While a growing number of genome sequences exist 
for mouse strains (Keane et al., 2011) and human cell lines (Auton et al., 2015), WGS data 
are still lacking for many commonly used cell lines. The wide availability of ChIP-seq input 
datasets provided a readily available set of genomic sequences that could be mined to 
enable accurate identification of ~45% of variants within three murine erythroid cell lines. 
We also found that the high numbers of background reads in ChIP-seq IP datasets made 
these data a rich resource for variant identification, provided that a wide range of IP types 
are used to avoid misclassification due to allelic imbalance. Notably, ~ 5% of variants in 
these cell lines are not found in the parent mouse strain, suggesting either incomplete 
parent strain WGS data or acquisition of novel mutations in cell culture. Other sources for 
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genomic sequences (DNase-seq, ATAC-seq, Hi-C, etc.) should be similarly amenable to 
extraction of genetic variants for any given cell line. 
In vivo sequence requirements for the GATA1-DNA interaction 
We subsequently exploited DNA sequence variation between erythroid cell lines as 
an unbiased screen for the genetic determinants of transcription factor binding and 
chromatin accessibility. Despite the functional similarity between these erythroid types, it 
was possible that associations between cis genetic differences and changes in TF binding 
were the result of distinct trans factor environments. Importantly, we demonstrated that 
mutations to the GATA1 motif (and others, data not shown) have consistent effects on 
GATA1 binding regardless of which cell line contains the mutation. While we cannot 
exclude that distinct trans factor environments may subtly influence TF binding at a given 
site, the primary determinants of TF binding and chromatin accessibility defined in this 
study are encoded in the underlying DNA sequence. 
Natural variation that disrupts the canonical WGATAR motif affected in vivo 
GATA1 binding in ways not entirely expected from in vitro studies. For example, 
mutations of the core nucleotides are less detrimental (ex. 29% binding reduction when G 
is mutated) to in vivo binding than expected, likely due to buffering by nearby contextual 
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TF factors. Further, different substitutions at a given location are tolerated to varying 
degrees, potentially due to the impact of the variant nucleotide on local DNA shape 
(Gordân et al., 2013). Our analysis also discovered modulatory sequence variants that 
leave the GATA motif intact but fall into neighboring TF binding sites. Spacing of the sites 
relative to the GATA element was important, and in some cases, inferences could be made 
as to the relevant trans-acting factor. Some motifs modulate GATA1 binding at 
unexpectedly large distances of > 50 bp, suggesting collaborative binding that may be 
direct (short-range chromatin bending or a TF complex bridged by additional contextual 
TF factors) or indirect (via promoting accessible chromatin). 
Contextual factors influence TF binding 
It is worth noting that studies aimed at examining collaborative TF binding often 
rely on global depletion of a TF, which can result in confounding secondary transcriptional 
effects. This drawback is avoided by the mining of cis-element variation as described here. 
Our results further support that in vivo TF binding is influenced in a variety of ways in 
addition to direct DNA contacts which on the one hand might ensure robustness by 
buffering against the effects of binding site mutations, and on the other hand increase 
specificity through reliance on contextual TFs. Moreover, the contribution of neighboring 
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DNA motifs to TF binding is consistent with previous findings that the binding profiles for 
a given TF can be dynamic across distinct cell lineages and differentiation states (Dubois-
Chevalier et al., 2014; Plasschaert et al., 2014; Wang et al., 2012). A striking example of 
such contextual effects is that motif alterations affect CTCF binding much less at 
constitutively occupied sites (6% median loss) when compared to sites at which binding is 
erythroid specific (60% median loss) or differentiation stage dependent (80% median 
loss). Along with the identification of major erythroid TF motifs that modulate CTCF 
binding at erythroid-specific binding sites, these results highlight that even the chromatin 
occupancy of a factor as widely expressed as CTCF can be modulated in a highly context 
dependent manner. It will be interesting to determine the contextual factors that convey 
the robustness of CTCF binding at constitutively occupied sites. 
 
Connections between chromatin accessibility and TF binding 
TFs can regulate chromatin occupancy of each other by modulating chromatin 
accessibility (Sherwood et al., 2014; Zaret and Carroll, 2011). We identify DNA motifs 
corresponding to major erythroid TFs that promote chromatin accessibility in erythroid 
cells. While these data suggest that many TFs can impact chromatin accessibility, specific 
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contexts, such as promoters and binding peaks for particular TFs, may rely on distinct 
subsets of these factors to establish and maintain accessibility. In particular, clear 
connections emerge between the regulation of TF binding and chromatin accessibility for 
GATA1, TAL1, and CTCF. For example, a KLF1-family DNA motif promotes both GATA1 
chromatin occupancy and chromatin accessibility at GATA1-bound sites. Since the binding 
of GATA1 itself also promotes chromatin accessibility at GATA1 peaks, the effect of the 
KLF1 motif on accessibility may be direct, indirect (by promoting GATA1 binding), or a 
combination of the two. These data establish clear relationships between TF binding and 
chromatin accessibility and suggest that genetic variants can easily perturb both of these 
highly related processes. 
Developing methods to exploit genetic variants in ChIP-seq data 
The work outlined here provides evidence that genetic variation impacts in vivo TF 
binding and chromatin accessibility in ways that are not entirely predictable from in vitro 
studies and that depend highly on local chromatin context. Analyzing variants in a context-
sensitive manner, as we and others (Gosselin et al., 2014; Heinz et al., 2013; Kilpinen et 
al., 2013; Maurano et al., 2015; Soccio et al., 2015; Tehranchi et al., 2016) have done, is 
critical to understanding and predicting the role of a particular variant in molecular 
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phenotypes and phenotypic variation and disease. Our analysis framework is also readily 
adaptable to additional tissue types and chromatin features as well as to the analysis of 
new datasets from different mouse strains or patient samples that exhibit genetic 
variation. These analysis strategies may even be applicable in settings of somatic tumor 
mutations to identify alterations in transcription factor binding that may impact cancer 
progression and metastasis. A limitation of our approach is that it compares quantitative 
information from ChIP-seq and DNase-seq experiments that may vary in design 
parameters (laboratory setting, read length, read depth, antibody lot, etc.). It is possible 
that applying our analytical approaches to experiments controlled for these parameters 
will provide even greater sensitivity at detecting contextual regulators of TF binding and 
chromatin accessibility. 
A relevant consideration here is that in our proof-of-concept experiments using a 
CRISPR-Cas9 guided mutagenesis followed by deep sequencing we were able to further 
define sequence requirements for GATA1 chromatin occupancy under conditions in which 
all the above variables can be controlled. This approach might also be generally useful to 
permit fine mapping of TF binding in cell types, such as our erythroid cell lines 
(unpublished observation) or genomic regions in which homologous recombination-
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mediated DNA repair is inefficient. Moreover, we envision that this method can be 
extended to afford higher resolution and made applicable for any DNA binding protein or 
chromatin features such as accessibility and histone modifications. 
ChIP-qPCR scaling allows for absolute quantification of ChIP-seq data 
The development of ChIP-sequencing has been important in the localization of TF 
occupancy and histone PTMs in a high-throughput manner. However, accurate 
normalization has been a longstanding challenge in the comparison of ChIP-seq data from 
distinct cellular states, given that chromatin-associated proteins cannot be assumed to be 
constant in their overall protein levels or subcellular localization (Kadauke et al., 2012). 
Recently, methods have been developed to spike chromatin from a different species 
(Bonhoure et al., 2014; Orlando et al., 2014). A second approach involves conducting a 
parallel ChIP targeting a control protein that is unlikely to change in chromatin occupancy 
between conditions (Guertin et al., 2018). While each of these approaches successfully 
controls a different source of variability within the ChIP procedure, they are technically 
demanding and make assumptions about their external controls that may not be widely 
applicable. 
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In order to properly evaluate temporal constraints of TF occupancy, we sought to 
develop a method that would allow for absolute normalization and comparison in distinct 
parts of the cell cycle. To this end, we directly used the gold standard for ChIP quantitation, 
ChIP-qPCR normalized to input chromatin, to linearly scale entire ChIP-seq datasets. We find 
that this method outperforms normalization based only on library size when using as few as 
6 qPCR loci. Moreover, for multiple histone modification, the scaling factors derived from 
ChIP-qPCR signals were validated by mass spectrometry. Importantly, this method can be 
used to retroactively normalize ChIP-seq data that have already been generated without an 
added spike-in, as is the case for the majority of existing public data.  
Deconvoluting the defining characteristics of a ChIP-seq peak 
The majority of prior studies describing changes in TF occupancy between interphase 
and mitosis focused only on intensity changes, or more simply, on differences in peak calling 
between these two cell cycle phases. However, since both chromatin accessibility (Hsiung et 
al., 2015) and nucleosome occupancy (Kelly et al., 2010) have been observed to change 
between interphase and mitosis, it cannot be assumed that chromatin-associated proteins 
would bind interphase and mitotic chromatin in the same way. From visual inspection of 
ChIP-seq browser tracks it became apparent that sites enriched for BRD4 were not only 
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dynamic in intensity but also in shape. In order to comprehensively define changes in both 
peak intensity and shape, we developed a PCA-based approach that identified the defining 
features of peaks as intensity (PC1), skew (PC2), and focality (PC3). Using this approach, we 
find that during mitosis BRD4 peaks tend to either become less focal with a minor loss in 
binding intensity (Type 1), or to undergo focal gains in intensity (Type 2). These patterns 
suggest that BRD4 may adopt both diffuse and focal modes of association with acetylated 
histones (see below) during mitosis, both of which require BRD4’s bromodomains. Notably, 
we identified that focal BRD4 mitotic peaks (Type 2 peaks) exhibit multiple features that 
would be consistent with mitotic bookmarking, including enrichment at erythroid genes, 
association with residual TSS Pol II binding, and enrichment at genes with faster reactivation 
kinetics following mitosis. 
BRD4 does not bookmark transcription in erythroid cells 
To test whether mitotic retention of BRD4 is of functional significance, we used JQ1 
to transiently remove BRD4 (as well as BRD2 and BRD3), from mitotic chromatin without 
perturbing overall protein levels. Surprisingly, transcriptional reactivation kinetics of all 
tested genes were unperturbed, indicating that the continued retention of BET proteins on 
chromatin throughout mitosis is dispensable for normal gene reactivation. This calls into 
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question the widely held notion of BRD4 as a bookmarking protein. We cannot, however, rule 
out a bookmarking function of BRD4 or other BET proteins at different genes or in different 
cell types. Also, it remains to be seen whether mitotically retained BRD4 serves a distinct 
function during mitosis other than bookmarking, or if it is simply a passive passenger 
anchored on chromatin by acetylated histones (see below). Regardless, these results 
underscore the need for transient, mitosis-restricted perturbations to allow classification of 
mitotic chromatin-associated factors as bookmarks. 
Histone PTMs are broadly retained on mitotic chromatin 
While chromatin undergoes large-scale architectural changes during mitosis (Gibcus 
et al., 2018; Naumova et al., 2013), several features of interphase chromatin remain, including 
retention of multiple transcription factors and chromatin accessibility. To this point, 
however, it has been largely unclear how much of the rich diversity in histone PTMs that exist 
on interphase chromatin is maintained during mitosis. Using both mass spectrometry and 
ChIP-seq we find that many histone methylation and acetylation PTMs are maintained during 
mitosis at similar global levels to interphase chromatin. While some acetyltransferases and 
deacetylases have been found to disassociate from chromatin (He et al., 2013; Kruhlak et al., 
2001; Valls et al., 2005) during mitosis, it remains unclear to what extent this applies to other 
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histone modifying enzymes, and thus to what extent mitotic histone modifications are being 
actively regulated. Notably, we find the behavior of several histone marks to be consistent 
with features of mitotic bookmarks, including TSS-proximal enrichment at lineage specific 
genes and at genes with fast reactivation kinetics following mitosis. Albeit correlative, these 
data suggest that histone marks may represent bone fide mitotic bookmarks. Nevertheless, 
rigorously testing of this hypothesis would require mitosis-specific modulation of histone 
modifications, which remains an unmet challenge. 
Histone acetylation tethers BRD4 to chromatin during mitosis 
Since BRD4 has multiple binding partners, including GATA1 and multiple acetyl 
histone marks, that are found on mitotic chromatin, it was not immediately obvious how 
BRD4 might bind to chromatin during mitosis. A simple approach such as intersecting binding 
peaks has limited value in answering this question since these chromatin features occupy the 
same regulatory regions. Rather, we employed a predictive modeling approach that considers 
the complex changes in peak intensity and shape occurring for BRD4 ligands and then 
compares, in an unbiased way, these changes to the changes in BRD4 occupancy. In doing so, 
we find that GATA1 and H3K27ac are dominant partners for BRD4 occupancy during 
interphase but not mitosis, while during mitosis BRD4 primarily binds H3K14ac, H3K122ac, 
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and H4K16ac. Notably, during both interphase and mitosis, a panel consisting of these 4 
acetyl marks outperforms each mark individually in predicting BRD4 occupancy, suggesting 
that these marks might act as non-redundant but independent substrates for BRD4. 
Alternatively, BRD4 might bind chromatin with higher affinity when interacting with multiple 
acetyl marks simultaneously, as has been previously observed (Dey et al., 2003). While we 
did observe retention of multiple di-acetylated histone peptides during mitosis by using 
bottom-up mass spectrometry, our ability to identify di-acetylated peptides was limited by 
typically short peptide lengths following trypsin digestion. Future studies might employ a 
middle-down proteomics (Sidoli et al., 2017) approach that would allow for longer peptides 
to be analyzed, thus offering further insight into whether di-acetylated histones are available 
on mitotic chromatin to recruit BRD4 binding in a combinatorial fashion. 
Concluding remarks 
In sum, our studies, aided by novel experimental and analytical approaches, have 
created insights about the sequence and temporal constraints regarding TF chromatin 
occupancy. In Chapter 2, we used genetic variation to more precisely define the functional 
components of transcription factor binding sites. These findings might ultimately enhance 
our mechanistic understanding of variation in inter-individual transcriptional output, 
 118 
molecular phenotypes, and common disease risk. In Chapter 3, we found that BRD4 does 
not measurably function as a mitotic bookmark of transcription in erythroid cells. Rather, 
we find evidence for a rich landscape of mitotically stable histone marks, some of which 
are predicted to instruct transcriptional reactivation during mitotic exit. These findings 
clarify the factors that might act as mitotic bookmarks of cellular identity and provide 
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Figure A. 1 – Commonly used murine erythroid cell systems have broadly correlated 
transcriptional profiles.  
DESeq2-normalized gene counts in G1E-ER4, MEL, or Erythroblast are plotted against each other, Spearman 




Figure A. 2 - Commonly used murine erythroid cell systems undergo gene activation and 
repression characteristic of erythroid differentiation.  
(a) Normalized gene counts in G1E-ER4, MEL, or Erythroblast for a panel of genes that are activated or 







Figure A. 3 - ENCODE ChIP-seq datasets used for variant calling and binding analysis 
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Figure A. 4 – Variant detection between erythroid cell lines 
(a) Schematic outlining methods for identifying genetic variation between murine erythroid ENCODE cell 
lines. The cell lines are listed with their strains of origin. Input ChIP-seq files corresponding to each of these 
cell lines are mapped to the reference mouse mm9 genome. The GATK HaplotypeCaller tool identifies variant 
nucleotide locations and the number of high-quality reads corresponding to reference or variant sequence at 
these locations. Zygosity is re-assigned based on stringent criteria based on proportion of variant read count. 
Binary genome segmentation identifies blocks of a particular variant zygosity and corrects variants of 
ambiguous zygosity within these blocks. Finally, a read depth filter is applied to any genome variants in order 
to identify high-confidence calls. These calls represent homozygous variants relative to the mm9 genome. 
Comparison of variant nucleotides between cell lines identifies the set of discriminatory SNPs (discSNPs) that 
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discriminate any pair of erythroid cell lines. (b) Table summarizing the variants identified by either ChIP-seq 
on the cell line of interest or from the Sanger institute’s characterization of the parent mouse strains. 
 
 
Figure A. 5 – Isolated discSNPs are associated with large changes in GATA1 binding and nearby 
gene transcription. 
(a) GATA1 ChIP-qPCR in differentiated G1E-ER4 (24h E2) and differentiated MEL (48h DMSO) at sites 
containing a single discSNP. The discSNP is associated with binding in G1E-ER4 only (G1, G2, G3) or in MEL 
only (M1). Mean +/- SEM, n= 3. (b) GATA1 ChIP-seq and RNA-seq intensity tracks (input and library size 
normalized, identical y-axis scales) reveals dramatic changes to both GATA1 binding and Kctd14 transcription 
in MEL and G1E-ER4 cells, which contain a single nucleotide change at the dotted vertical line (no other 




Figure A. 6 – Cas9-mediated editing of the Bola1-proximal GATA1 binding site 
 (a) Differential expression of Bola1 and GATA1 binding to the Bola1-proximal GATA1 peak seen in G1E-ER4 
and MEL cells. Expression and binding q-values are Benjamini-Hochberg adjusted using DESeq2. (b) 
Sequence of the Bola1-proximal GATA1 peak in wild type G1E-ER4, wild type MEL, or the 5 MEL clones 
containing bi-allelic deletions. Canonical GATA1 binding sequence (WGATAR) is highlighted. 
A B   
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Figure A. 7 – GATA1 binds multiple GATA family consensus motif sequences. 
 (a) The majority of GATA1 peaks have a GATA1 motif, while about half of those that don’t have a motif for a 
different GATA1 factor and the rest have no GATA motif at all. (b) GATA1 binding intensities stratified by 




Figure A. 8 – GATA1 binding is similarly disrupted by mutations in its consensus motif, 
regardless of the cell line in which the disruption occurs. 
The percent impact on GATA1 binding intensity associated with mutations at various positions when stratified 
by the cell line with the intact GATA1 motif and the cell line with the disrupted GATA1 motif. Data sparsity at 




Figure A. 9 – Spectrum of deletions created by Cas9-targeting to the GATA1 motif within the 
Bola1-proximal GATA1 binding site. 
(a) Histogram of deletion length generated by targeting Cas9 to the Bola1-proximal GATA1 peak. (b) Positions 
of deletions relative to the WGATAR motif (red lines) plotted vs deletion frequency in sequenced ChIP Input 
material. 
A B A B 
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Figure A. 10 – Motifs that are more likely to bind GATA1 or a nearby cofactor are more 
deleterious to GATA1 binding when mutated. 
DiscSNPs that directly disrupt a GATA/non-GATA motif are plotted by their impact on GATA1 binding, 
categorized by the predicted MEME score of the intact motif. Wilcoxon, * p < 0.01, ** p = 1.8e-7 
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Figure A. 11 – Comparisons of GATA1 binding prediction using different FDR cutoffs 
Sensitivity of identification of GATA1 binding peaks at an FDR of 0.3 (dotted line) when either using the GATA 
PWM alone, the GATA1 PWM + contextual motif PWMs, or control shuffles of contextual motif PWMs 
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Figure A. 12 – Assigning TFs to their consensus binding motifs in erythroid cells. 
(a) Density plot of log2-scale RNA-seq expression values for TFs corresponding to all TF DNA motifs in the 
Cis-BP motif database in differentiated erythroid cells (G1E-ER4). (b) Transcription factor motifs highly 
related to KLF1, NFE2, TCF12, and CTCF are depicted along with expression in transcripts per million (TPM) 
of the corresponding factor in differentiated G1E-ER4 cells (24h E2). 
 
 Figure A. 13 – Examining tissue-specificity in murine CTCF binding profiles 
CTCF peaks called in 23 distinct tissues were overlapped and categorized as constitutive (present in >60% of 
tissues) or variable (present in <20% of tissues). The subset of variable peaks that are present in an erythroid 
cell type and those that are not present in G1E proerythroblasts but are found in differentiated G1E-ER4 




Figure A. 14 – Chromatin accessibility is largely unchanged during erythroid differentiation. 
Log-log plot between DNase signal in an undifferentiated state vs differentiated state for either G1E/G1E-ER4 
or MEL. Pearson correlation coefficient is shown on the plot. 
 
Figure A. 15 – DiscSNPs impact TF binding and chromatin accessibility in a highly correlated 
manner. 
For discSNPs disrupting either a GATA1 or CTCF motif within GATA1 and CTCF peaks, respectively, Pearson 
correlation coefficients between differential chromatin occupancy and differential DNase1 accessibility at a 
range of FDR cutoffs for differential binding. Bars are 95% confidence intervals, * p <0.05 (Fisher’s z-
transform). 
 139 
             
  
Figure A. 16 – GATA2 binding in undifferentiated erythroid cells correlates with GATA1 
binding and accessibility in differentiated erythroid cells.  
GATA2 binding in undifferentiated cells and DNase intensity in undifferentiated cells (bottom), or with DNase 
intensity in differentiated cells (top left) or GATA1 intensity in differentiated cells (top right). Binding is 
examined at 15,527 GATA1 peaks called in differentiated erythroid cells. Pearson correlation coefficient is 
shown on the plot. 
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Figure A. 17 – BRD4 mitotic binding profiles are highly similar using either nocodazole or 
ro3306 synchronization 
(a) Principal component analysis (PCA) of qPCR-scaled BRD4 peak intensities from each ChIP-seq replicate. 
Replicates are either unsynchronized (red) or synchronized in mitosis using nocodazole (green) or ro3306 
(blue). (b) Heatmap depicting mean Spearman correlation r comparing BRD4 peak intensities in interphase, 
nocodazole-synchronized mitosis, or ro3306-synchronized mitosis. Correlations are done for all replicates 





Figure A. 18 – Library normalization underestimates BRD4 mitotic chromatin binding 
(a) BRD4 ChIP-qPCR in interphase (n = 3) or mitosis (n = 5) at 17 BRD4 interphase peaks. (b) Ratio of mitotic 
to interphase binding of BRD4 at 17 interphase BRD4 peaks measured either by ChIP-qPCR or ChIP-
sequencing (library-size normalized). Dotted line represents y = x. 
 
Figure A. 19 – Significant changes in BRD4 peak intensities during mitosis 
Mitotic retention of BRD4 binding at 5343 interphase/mitotic peaks, scaled by ChIP-qPCR data. Peaks are 
separated by their significance of altered binding, measured by a Wilcoxon test p < 0.05. Peaks with no 




Figure A. 20 – BRD4 peaks are defined by the same characteristics during both interphase and 
mitosis 
(a) PC eigenvector profiles derived from either interphase or mitotic BRD4 data. (b) Density plot of peak 
projection values onto PC 1/2/3 during either interphase or mitosis 
 
 
Figure A. 21 – BRD4 peak classification based on PCA-based analysis vs peak-calling 
Distribution of Type 1 or Type 2 peaks called during interphase only (green), mitosis only (blue), or during 
both phases (red). 
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Figure A. 22 – ChIP-qPCR confirms TSS-proximal Pol II binding at Type 2 genes during mitosis 
in a paused manner. 
Pol II ChIP-qPCR in asynchronous or nocodazole-synchronized mitotic cells, assessed in gene TSS-proximal 
or TTS-proximal (Atp5b gene) regions. All values are mean +/- SEM, n = 3. 
 
 
Figure A. 23 – Transient BRD4 mitotic inhibition with 1 uM JQ1 does not impact transcription 
following mitosis 
Comparison of RT-qPCR quantities for 16 primary transcripts after treatment with either 1 uM JQ1 or DMSO 
during mitosis. Dotted black line represents equal levels; dotted red lines show 2-fold difference. Data are 
normalized to GAPDH mature transcript and to mean quantity across all time points. 
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Figure A. 24 – ChIP-qPCR of histone PTMs in interphase and mitosis 
Interphase and mitotic ChIP-qPCR for histone PTMs at a set of BRD4 binding peaks and gene TSS regions. 




Figure A. 25 – Table of ChIP-qPCR and RNA RT-qPCR primers used in Chapter 2 
Experiment Location Type Left Primer Right Primer
SuppFig3b_Endogenous GATA1 
ChIP G1 endogenous ctctgtccccagaaacaatg tttacactccactcctctgagc
SuppFig3b_Endogenous GATA1 
ChIP G2 endogenous ttgctgctgctatctgagaa ggaatgcactatttgaaaactctc
SuppFig3b_Endogenous GATA1 
ChIP G3 endogenous gaagccaaaccatgtccaac atactgactgcgtgtgcttctc
SuppFig3b_Endogenous GATA1 
ChIP M1 endogenous cagagccaagtgtgtggcta cagagccaagtgtgtggcta
Fig2c_Ectopic GATA1 site testing
Panel 1 (AGATAA -> 
AGATAG) endogenous aaggcagtgacctgctttct ttcgatcatttccccttgat
Fig2c_Ectopic GATA1 site testing
Panel 2 (AGATAG -> 
AGATGG, same site as G3 
above) endogenous gaagccaaaccatgtccaac atactgactgcgtgtgcttctc
Fig2c_Ectopic GATA1 site testing
Panel 3 (AGATAA -> 
AGATGA) endogenous gctctggtcttacgggaaca cctaggctgaccttgtgacc
Fig2c_Ectopic GATA1 site testing
Panel 4 (AGATAA -> 
AGAAAA, same site as G1 
above) endogenous ctctgtccccagaaacaatg tttacactccactcctctgagc
Fig2c_Ectopic GATA1 site testing barcode_reference_allele ectopic gacctgcagttcgaagttcct cataagaacaagcttcttaacaac
Fig2c_Ectopic GATA1 site testing barcode_variant_allele ectopic gacctgcagttcgaagttcct cagcctgtcgataaccacgttagt





Fig2d_GATA1 Bola1 occupancy HS2 endogenous GGGTGTGTGGCCAGATGTTT CACCTTCCCTGTGGACTTCCT
Fig2d_GATA1 Bola1 occupancy Bola1 endogenous agctcatggccaaaatgg atctccaaactgctccagctc
Fig2d_Bola1 RNA qRT-PCR Bola1 endogenous GACCGGAAATTCGGTTGTTAG CGCACTTAGCATTCGCTTTG
Fig2d_Bola1 RNA qRT-PCR B-actin endogenous ACACCCGCCACCAGTTC TACAGCCCGGGGAGCAT
Fig2d_Bola1 RNA qRT-PCR Gapdh endogenous AGGTTGTCTCCTGCGACTTCA
CCAGGAAATGAGCTTGACAA
AG
Fig2d_Bola1 RNA qRT-PCR Fog1 endogenous
GTCAGGGTGAAGACAGAACT
G TGTGGCAGAAAGAGTGTCC
Fig2d_Bola1 RNA qRT-PCR Gata2 endogenous CACCCCTAAGCAGAGAAGCAA
TGGCACCACAGTTGACACAC
T
Fig2d_Bola1 RNA qRT-PCR Klf1 endogenous CACGCACACGGGAGAGAAG CGTCAGTTCGTCTGAGCGAG
Fig2d_Bola1 RNA qRT-PCR Pabpc1 endogenous CTACCAGCCAGCACCTCCTT TGCAGCACGGTTCTGAGTCT
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Figure A. 26 - Table of ChIP-qPCR and RNA RT-qPCR primers used in Chapter 3 
Experiment Location Type Left Primer Right Primer
ChIP-qPCR Atp5b promoter tccaaggacagtcaaagacg gaggtttttggcggaactac
ChIP-qPCR Atp5b TTS gccttacaacgtgtttgagc tggtgagattgcaggtcttg
ChIP-qPCR Brca1 66 kb downstream ttctggtgctgattgtctcc ccaggatgcccagaatgtag
ChIP-qPCR CD4 promoter ctcgagactttgcaaacagg accaggcttcctgtcttttc
ChIP-qPCR Cdk12 promoter gccgtttcggtttaatctagtg ctcacaccgacacctcacag
ChIP-qPCR Cpeb4 40 kb upstream tttctcaaaaccgctggaac tgggacaggtttgttaactgg
ChIP-qPCR Csf2rb2 promoter ctggacttagcccttgcttg cactgtgcattggattggag
ChIP-qPCR Hbb-b1 promoter atcctgtgtgagcagattgg gcatccagggagaaatatgc




ChIP-qPCR Med1 promoter cgcgagattaatcgtgttcc aggacgaaatcagccaacc
ChIP-qPCR Nfe2 3 kb upstream ttgctggattgcctactgg tgtggggcactgataaaagg
ChIP-qPCR Nfe2 promoter ttgctggattgcctactgg tgtggggcactgataaaagg
ChIP-qPCR Nfe2l1 promoter tgggcggtgttgtaagttag ggcgtcaatgctccattatc
ChIP-qPCR Nfe2l2 promoter caactccaagtccatcatgc cacctctgctgcaagtagcc
ChIP-qPCR Nt5c3 3 kb downstream gcccagtgaagacaagataagg attaaacccagggcctcttc
ChIP-qPCR Pabpc1 promoter ctggcgcttaagatgttctg ttttcgagtcctttttaccactg
ChIP-qPCR Runx1 promoter tgaagcactgtggatatgaagg ttcaggagaggtgcgttttc
ChIP-qPCR Suv420h2 1 kb downstream tgtgtgtgctgacattcgag cccctcttgcaaaacagatg
ChIP-qPCR Tmem131 23kb downstream tcacaaccagtcaagcagtg agcatatgggacaggtggag
ChIP-qPCR Tmem131 2kb downstream gagaactaccactgaatttgctg tccctgaggatcttctgtgtc
ChIP-qPCR Tnp1 25 kb upstream tgggctcgctctctttaatc acagaaaccctacacagtcacc
ChIP-qPCR Uros promoter atgaggaagatgggaggatg gctaaattgcttcctccttgg
ChIP-qPCR Zfpm1 2 kb downstream aacttcaaacgtgggagagg gcctatcatgtcagccatctg
RT-qPCR Gapdh
mature transcript 
(exon 6) aggttgtctcctgcgacttca ccaggaaatgagcttgacaaag
RT-qPCR Gata2
primary transcript 
(intron 3 - exon 4) aagcaggccttgtgtctttc cacaggcattgcacaggtag
RT-qPCR Gata2
primary transcript 
(exon 1 - intron 1) ggctctcctggtgtctcttactc tccctccaacctaggaatgtc
RT-qPCR Gata2
primary transcript 
(intron 1 - exon 2) tgtccttcacattccctctg tccactactgtgtcttgggaac
RT-qPCR Gp1ba
primary transcript 
(intron 1 - exon 2) agcagtgaagggctaaaagc tacaagtgtgctgggaatgc
RT-qPCR Hba-a1
primary transcript 
(intron 2 - exon 3) tcagggtgtccactttgtctc ggcaaggaatttgtccagag
RT-qPCR Hbb-b1
primary transcript 
(intron 2 - exon 3) gcctgcagtatctggtatttttg tgaaatccttgcccaggtg
RT-qPCR Ikzf2
primary transcript 
(exon 1 - intron 1) gctggaaatggtgatgactg aaagaagtctgcgccaacag
RT-qPCR Kit
primary transcript 
(intron 7 - exon 8) tgttcagccaactgatgagg catgccatttatgagcctgtc
RT-qPCR Lyl1
primary transcript 
(exon 2 - intron 2) agctaactgccttgggaagag gggtcatgaacactttgtaggc
RT-qPCR Myb
primary transcript 
(intron 1 - exon 2) tgctgaagcgtttctgtctg agcccatcgtagtcatggtc
RT-qPCR Myc
primary transcript 
(exon 1 - intron 1) tagtgctgcatgaggagacac aatgccaatgagtggtggag
RT-qPCR Myc
primary transcript 
(intron 1 - exon 2) tagacttgcttcccttgctg tcgtcgcagatgaaataggg
RT-qPCR Nfe2
primary transcript 
(intron 1 - exon 2) aattctgcacgaggacaacc ctccacaagcacaaaggattc
RT-qPCR Pabpc1
mature transcript 
(exon 1 - exon 2) cgtacgtgaacttccagcag acatgatgcgtactggcttg
RT-qPCR Pabpc1
primary transcript 
(intron 2 - exon 3) tctgaagttcctgggattgg tagcccttggagccattttc
RT-qPCR Runx1
primary transcript 
(intron 1 - exon 2) gcatttgtcccttggttgac ctgccgagtagttttcatcg
RT-qPCR Uros
primary transcript 
(intron 7 - exon 8) ccattcccacttccattcc tagctcttcaggctcccttg
RT-qPCR Zfpm1
primary transcript 
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